{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "04",
                "@timestamp": "2023-09-04T04:26:29.000029-04:00",
                "@year": "2023",
                "@month": "09"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "06"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2023-06-01T16:51:28.455Z",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp-car"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Japan",
                            "@afid": "60010925",
                            "@country": "jpn",
                            "city": "Kashiwa",
                            "organization": [
                                {"$": "Department of Gastroenterology and Gastrointestinal Oncology"},
                                {"$": "National Cancer Center Hospital East"}
                            ],
                            "affiliation-id": {
                                "@afid": "60010925",
                                "@dptid": "103589809"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-905f0525543db180819922ab5d32eae9-1",
                            "ce:source-text": "Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan",
                            "@dptid": "103589809"
                        },
                        "author": [
                            {
                                "preferred-name": {
                                    "ce:given-name": "T.",
                                    "ce:initials": "T.",
                                    "ce:surname": "Yoshino",
                                    "ce:indexed-name": "Yoshino T."
                                },
                                "@author-instance-id": "OB2BibRecID-948433298-53cfacc5ec1b843ddcb2b508359ba6f0-1",
                                "@seq": "1",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Yoshino",
                                "@auid": "57205400013",
                                "@orcid": "0000-0002-0489-4756",
                                "ce:indexed-name": "Yoshino T."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "H.",
                                    "ce:initials": "H.",
                                    "ce:surname": "Bando",
                                    "ce:indexed-name": "Bando H."
                                },
                                "@author-instance-id": "OB2BibRecID-948433298-85b948717ca0689abaebf65a878e6579-1",
                                "@seq": "3",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Bando",
                                "@auid": "28267511400",
                                "ce:indexed-name": "Bando H."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "S.",
                                    "ce:initials": "S.",
                                    "ce:surname": "Mishima",
                                    "ce:indexed-name": "Mishima S."
                                },
                                "@author-instance-id": "OB2BibRecID-948433298-74b3ad1b7834543d61a929c3e4ef79a4-1",
                                "@seq": "25",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Mishima",
                                "@auid": "57203743338",
                                "ce:indexed-name": "Mishima S."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "Y.",
                                    "ce:initials": "Y.",
                                    "ce:surname": "Nakamura",
                                    "ce:indexed-name": "Nakamura Y."
                                },
                                "@author-instance-id": "OB2BibRecID-948433298-afd6f52c8436aa54be347ba22ad2f179-1",
                                "@seq": "26",
                                "ce:initials": "Y.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Nakamura",
                                "@auid": "55726843400",
                                "ce:indexed-name": "Nakamura Y."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "@afid": "60002644",
                            "city": "Valencia",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "INCLIVA Biomedical Research Institute"},
                                {"$": "University of Valencia"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002644",
                                    "@dptid": "113168240"
                                },
                                {"@afid": "60272547"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-fd01b8cc780e29e6a39c07d0270f7199-1",
                            "ce:source-text": "Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia",
                            "@dptid": "113168240"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "A.",
                                "ce:initials": "A.",
                                "ce:surname": "Cervantes",
                                "ce:indexed-name": "Cervantes A."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-ba3e16e77f919590aaa463dbc6828310-1",
                            "@seq": "2",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Cervantes",
                            "@auid": "7006000690",
                            "ce:indexed-name": "Cervantes A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60271969",
                            "@country": "esp",
                            "city": "Madrid",
                            "organization": [
                                {"$": "CIBERONC"},
                                {"$": "Instituto de Salud Carlos III"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60271969"},
                                {"@afid": "60001602"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-9856ca3ebd3a2904d4f2354619c58139-1",
                            "ce:source-text": "CIBERONC, Instituto de Salud Carlos III, Madrid, Spain"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "A.",
                                "ce:initials": "A.",
                                "ce:surname": "Cervantes",
                                "ce:indexed-name": "Cervantes A."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-ba3e16e77f919590aaa463dbc6828310-1",
                            "@seq": "2",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Cervantes",
                            "@auid": "7006000690",
                            "ce:indexed-name": "Cervantes A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60026777",
                            "@country": "ita",
                            "city": "Naples",
                            "organization": [
                                {"$": "Oncology Unit"},
                                {"$": "Department of Precision Medicine"},
                                {"$": "Universit√† degli Studi della Campania \u2018L. Vanvitelli\u2019"}
                            ],
                            "affiliation-id": {
                                "@afid": "60026777",
                                "@dptid": "123844479"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-a2d16789af2724061cf0424948e92dc3-1",
                            "ce:source-text": "Oncology Unit, Department of Precision Medicine, Universita degli Studi della Campania \u2018L. Vanvitelli\u2019, Naples, Italy",
                            "@dptid": "123844479"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "E.",
                                "ce:initials": "E.",
                                "ce:surname": "Martinelli",
                                "ce:indexed-name": "Martinelli E."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-ba5e0db2df7f5c8c6923cec9bf698950-1",
                            "@seq": "4",
                            "ce:initials": "E.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Martinelli",
                            "@auid": "7005920149",
                            "ce:indexed-name": "Martinelli E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "address-part": "Fukuoka",
                            "@afid": "60185923",
                            "@country": "jpn",
                            "organization": [
                                {"$": "Department of Surgery and Science"},
                                {"$": "Graduate School of Medical Sciences"},
                                {"$": "Kyushu University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60185923",
                                    "@dptid": "125085836"
                                },
                                {"@afid": "60011047"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-fe9b1a21e79fa1a8da1c554be1c17f56-1",
                            "ce:source-text": "Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan",
                            "@dptid": "125085836"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "E.",
                                "ce:initials": "E.",
                                "ce:surname": "Oki",
                                "ce:indexed-name": "Oki E."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-e9c50d7ea21f40fda0980008a44b981e-1",
                            "@seq": "5",
                            "ce:initials": "E.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Oki",
                            "@auid": "34572593400",
                            "ce:indexed-name": "Oki E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60082502",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Sun Yat-Sen University Cancer Center and State Key Laboratory of Oncology in South China"}
                            ],
                            "affiliation-id": {
                                "@afid": "60082502",
                                "@dptid": "105824598"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-c061b9c88ccb813b47bec440a02d478e-1",
                            "ce:source-text": "Department of Medical Oncology, Sun Yat-sen University Cancer Center and State Key Laboratory of Oncology in South China, Guangzhou, China",
                            "@dptid": "105824598"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "R. H.",
                                "ce:initials": "R.H.",
                                "ce:surname": "Xu",
                                "ce:indexed-name": "Xu R.H."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-723dccc9c7564f88e8c3b936d73aacd2-1",
                            "@seq": "6",
                            "ce:initials": "R.-H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Xu",
                            "@auid": "8662243500",
                            "ce:indexed-name": "Xu R.-H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Indonesia",
                            "@afid": "60069378",
                            "@country": "idn",
                            "city": "Jakarta",
                            "organization": [
                                {"$": "Hematology-Medical Oncology Division"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Cipto Mangunkusumo National General Hospital/Universitas Indonesia"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60069378",
                                    "@dptid": "100277496"
                                },
                                {"@afid": "60069377"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-d941156c3f8156e22702203cdd77d8ff-1",
                            "ce:source-text": "Hematology-Medical Oncology Division, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital/Universitas Indonesia, Jakarta, Indonesia",
                            "@dptid": "100277496"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "N. A.",
                                "ce:initials": "N.A.",
                                "ce:surname": "Mulansari",
                                "ce:indexed-name": "Mulansari N.A."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-c7692edfa09c50e91ef99782c58926a0-1",
                            "@seq": "7",
                            "ce:initials": "N.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Mulansari",
                            "@auid": "36519326000",
                            "ce:indexed-name": "Mulansari N.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "India",
                            "@afid": "60005996",
                            "@country": "ind",
                            "city": "Bengaluru",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "HCG Hospital and St. John's Medical College"}
                            ],
                            "affiliation-id": {
                                "@afid": "60005996",
                                "@dptid": "129770071"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-a2f33aebff1a335dcab8d3f3dfc5e605-1",
                            "ce:source-text": "Department of Medical Oncology, HCG Hospital and St. Johns Medical College, Bengaluru, India",
                            "@dptid": "129770071"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "K.",
                                "ce:initials": "K.",
                                "ce:surname": "Govind Babu",
                                "ce:indexed-name": "Govind Babu K."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-c50ca5bdf77831c4a8918c6ce38847ea-1",
                            "@seq": "8",
                            "ce:initials": "K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Govind Babu",
                            "@auid": "6507009848",
                            "ce:indexed-name": "Govind Babu K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60276990",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Seoul St. Mary's Hospital"},
                                {"$": "College of Medicine"},
                                {"$": "The Catholic University of Korea"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60276990",
                                    "@dptid": "129445379"
                                },
                                {"@afid": "60001727"},
                                {"@afid": "60003087"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-e64a099ebd2ff7d13b7d6d8e6905742f-1",
                            "ce:source-text": "Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea",
                            "@dptid": "129445379"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "M. A.",
                                "ce:initials": "M.A.",
                                "ce:surname": "Lee",
                                "ce:indexed-name": "Lee M.A."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-71803c991660c6a8cf96f75f627e5509-1",
                            "@seq": "9",
                            "ce:initials": "M.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lee",
                            "@auid": "58003653900",
                            "ce:indexed-name": "Lee M.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "address-part": "Selangor",
                            "@afid": "121989463",
                            "@country": "mys",
                            "organization": [
                                {"$": "Department of Oncology and Nuclear Medicine"},
                                {"$": "Thomson Hospital Kota Damansara"}
                            ],
                            "affiliation-id": {
                                "@afid": "121989463",
                                "@dptid": "129769432"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-9ac2c7fa5729591084d90bcd5ecc4bd5-1",
                            "ce:source-text": "Department of Oncology and Nuclear Medicine, Thomson Hospital Kota Damansara, Selangor, Malaysia",
                            "@dptid": "129769432"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "C. K.",
                                "ce:initials": "C.K.",
                                "ce:surname": "Tan",
                                "ce:indexed-name": "Tan C.K."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-8cda3554e1294b40821fb71377a8760b-1",
                            "@seq": "10",
                            "ce:initials": "C.K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tan",
                            "@auid": "58288943100",
                            "ce:indexed-name": "Tan C.K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Philippines",
                            "@afid": "60071478",
                            "@country": "phl",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "University of the Philipppines-Philippine General Hospital"},
                                {"$": "St. Lukes Cancer Institute-Global City"}
                            ],
                            "affiliation-id": {
                                "@afid": "60071478",
                                "@dptid": "129770427"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-c896a0dd139abe9233e27e48da3b6a91-1",
                            "ce:source-text": "Department of Medical Oncology, University of the Philipppines-Philippine General Hospital, St. Lukes Cancer Institute-Global City, The Philippines",
                            "@dptid": "129770427"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "G.",
                                "ce:initials": "G.",
                                "ce:surname": "Cornelio",
                                "ce:indexed-name": "Cornelio G."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-7e08662a81a0a89fc7a91c9b08ea1fca-1",
                            "@seq": "11",
                            "ce:initials": "G.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Cornelio",
                            "@auid": "6603213207",
                            "ce:indexed-name": "Cornelio G."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60031809",
                            "@country": "sgp",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "National Cancer Centre Singapore"}
                            ],
                            "affiliation-id": {
                                "@afid": "60031809",
                                "@dptid": "104614771"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-74cd752f2d5f00584b2499b1a437b6c1-1",
                            "ce:source-text": "Division of Medical Oncology, National Cancer Centre Singapore, Singapore",
                            "@dptid": "104614771"
                        },
                        "author": [
                            {
                                "preferred-name": {
                                    "ce:given-name": "D. Q.",
                                    "ce:initials": "D.Q.",
                                    "ce:surname": "Chong",
                                    "ce:indexed-name": "Chong D.Q."
                                },
                                "@author-instance-id": "OB2BibRecID-948433298-0eafb63a66b9e04fd875e78c797ddd6b-1",
                                "@seq": "12",
                                "ce:initials": "D.Q.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chong",
                                "@auid": "55533963500",
                                "ce:indexed-name": "Chong D.Q."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "C.",
                                    "ce:initials": "C.",
                                    "ce:surname": "Chua",
                                    "ce:indexed-name": "Chua C."
                                },
                                "@author-instance-id": "OB2BibRecID-948433298-bc994a6141bc888a29462f6d3ae06c7b-1",
                                "@seq": "17",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chua",
                                "@auid": "55639224600",
                                "ce:indexed-name": "Chua C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60073387",
                            "@country": "twn",
                            "city": "Kaohsiung",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Kaohsiung Medical University Hospital and Centre for Cancer Research"},
                                {"$": "Kaohsiung Medical University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60073387",
                                    "@dptid": "109684889"
                                },
                                {"@afid": "60012256"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-7a502cd0b4f73aaa905ed43409ad44d6-1",
                            "ce:source-text": "Department of Internal Medicine, Kaohsiung Medical University Hospital and Centre for Cancer Research, Kaohsiung Medical University, Kaohsiung",
                            "@dptid": "109684889"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "L. T.",
                                "ce:initials": "L.T.",
                                "ce:surname": "Chen",
                                "ce:indexed-name": "Chen L.T."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-d9d02bf0f76f8197d32fc376fd3bd143-1",
                            "@seq": "13",
                            "ce:initials": "L.-T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chen",
                            "@auid": "7409440415",
                            "ce:indexed-name": "Chen L.-T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60010037",
                            "@country": "twn",
                            "city": "Tainan",
                            "organization": [
                                {"$": "National Institute of Cancer Research"},
                                {"$": "National Health Research Institutes"}
                            ],
                            "affiliation-id": {
                                "@afid": "60010037",
                                "@dptid": "103549690"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-2ec5c6d05e162f9e29419990445efcd7-1",
                            "ce:source-text": "National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan",
                            "@dptid": "103549690"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "L. T.",
                                "ce:initials": "L.T.",
                                "ce:surname": "Chen",
                                "ce:indexed-name": "Chen L.T."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-d9d02bf0f76f8197d32fc376fd3bd143-1",
                            "@seq": "13",
                            "ce:initials": "L.-T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chen",
                            "@auid": "7409440415",
                            "ce:indexed-name": "Chen L.-T."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "60002620",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "118220109"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-58ec24d11c9bfd85fdfb6070d4a25173-1",
                            "ce:source-text": "Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok",
                            "@dptid": "118220109"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S.",
                                "ce:initials": "S.",
                                "ce:surname": "Tanasanvimon",
                                "ce:indexed-name": "Tanasanvimon S."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-c2517896437affc0e5c775ec027b7326-1",
                            "@seq": "14",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tanasanvimon",
                            "@auid": "23089332900",
                            "ce:indexed-name": "Tanasanvimon S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60006964",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Phramongkutklao Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60006964",
                                "@dptid": "112584168"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-8c0888b098973768e02d1325377f573d-1",
                            "ce:source-text": "Division of Medical Oncology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand",
                            "@dptid": "112584168"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "N.",
                                "ce:initials": "N.",
                                "ce:surname": "Prasongsook",
                                "ce:indexed-name": "Prasongsook N."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-dc6a96cb5eba1458ae4b3e0c1dcecfe5-1",
                            "@seq": "15",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Prasongsook",
                            "@auid": "57191860850",
                            "ce:indexed-name": "Prasongsook N."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "60073385",
                            "city": "Taipei",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "National Taiwan University Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60073385",
                                "@dptid": "113273045"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-2b7ae5c567703e21de615a233604f387-1",
                            "ce:source-text": "Department of Oncology, National Taiwan University Hospital, Taipei",
                            "@dptid": "113273045"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "K. H.",
                                "ce:initials": "K.H.",
                                "ce:surname": "Yeh",
                                "ce:indexed-name": "Yeh K.H."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-d6502bb23d262dc6663da46c2bf18677-1",
                            "@seq": "16",
                            "ce:initials": "K.-H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yeh",
                            "@auid": "7201438906",
                            "ce:indexed-name": "Yeh K.-H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60025370",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": [
                                {"$": "Graduate Institute of Oncology"},
                                {"$": "National Taiwan University College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60025370",
                                "@dptid": "108114181"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-aa479418287b65e4d4dc828d8478a880-1",
                            "ce:source-text": "Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan",
                            "@dptid": "108114181"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "K. H.",
                                "ce:initials": "K.H.",
                                "ce:surname": "Yeh",
                                "ce:indexed-name": "Yeh K.H."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-d6502bb23d262dc6663da46c2bf18677-1",
                            "@seq": "16",
                            "ce:initials": "K.-H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yeh",
                            "@auid": "7201438906",
                            "ce:indexed-name": "Yeh K.-H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Philippines",
                            "@afid": "60071449",
                            "@country": "phl",
                            "city": "Manila",
                            "organization": [
                                {"$": "Department of Surgery"},
                                {"$": "University of the Philippines-College of Medicine and University of the Philippines-Philippine General Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60071449",
                                    "@dptid": "100286554"
                                },
                                {"@afid": "60071478"},
                                {"@afid": "60071495"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-d5692386ca14015e421f66ef369107e7-1",
                            "ce:source-text": "Department of Surgery, University of the Philippines-College of Medicine and University of the Philippines-Philippine General Hospital, Manila, The Philippines",
                            "@dptid": "100286554"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "M. D.",
                                "ce:initials": "M.D.",
                                "ce:surname": "Sacdalan",
                                "ce:indexed-name": "Sacdalan M.D."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-bdf27ff3c994f7dc857065812bb240c9-1",
                            "@seq": "18",
                            "ce:initials": "M.D.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sacdalan",
                            "@auid": "57201651001",
                            "ce:indexed-name": "Sacdalan M.D."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "129768385",
                            "@country": "mys",
                            "city": "Nilai",
                            "organization": [
                                {"$": "Department of Radiotherapy & Oncology"},
                                {"$": "Aurelius Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "129768385",
                                "@dptid": "129769533"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-4763f96a4dd93b8c93c0193c288b28b6-1",
                            "ce:source-text": "Department of Radiotherapy & Oncology, Aurelius Hospital, Nilai, Malaysia",
                            "@dptid": "129769533"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "W. J.",
                                "ce:initials": "W.J.",
                                "ce:surname": "Sow (Jenson)",
                                "ce:indexed-name": "Sow (Jenson) W.J."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-80dc7b3cdc3e9894a176cc05af9b66b4-1",
                            "@seq": "19",
                            "ce:initials": "W.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sow (Jenson)",
                            "@auid": "58289728300",
                            "ce:indexed-name": "Sow (Jenson) W.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60016329",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Division of Hematology-Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Sungkyunkwan University School of Medicine"},
                                {"$": "Samsung Medical Centre"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60016329",
                                    "@dptid": "113016172"
                                },
                                {"@afid": "60020857"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-7138ca36dd8b4cb906c9ed7be8d5e4a8-1",
                            "ce:source-text": "Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea",
                            "@dptid": "113016172"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S. T.",
                                "ce:initials": "S.T.",
                                "ce:surname": "Kim",
                                "ce:indexed-name": "Kim S.T."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-df0f4e8aedb20a51827e7d4c8783d6e8-1",
                            "@seq": "20",
                            "ce:initials": "S.T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kim",
                            "@auid": "56569111000",
                            "ce:indexed-name": "Kim S.T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "India",
                            "address-part": "Tamil Nadu",
                            "@afid": "60000653",
                            "@country": "ind",
                            "city": "Vellore",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Christian Medical College"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000653",
                                "@dptid": "103068312"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-2e0ed335418c92a06bd959f2f1f18bdb-1",
                            "ce:source-text": "Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India",
                            "@dptid": "103068312"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "R. T.",
                                "ce:initials": "R.T.",
                                "ce:surname": "Chacko",
                                "ce:indexed-name": "Chacko R.T."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-4e871abf3f694f1ede49fdb8281ad9eb-1",
                            "@seq": "21",
                            "ce:initials": "R.T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chacko",
                            "@auid": "26659876000",
                            "ce:indexed-name": "Chacko R.T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Indonesia",
                            "@afid": "60069378",
                            "@country": "idn",
                            "city": "Jakarta",
                            "organization": [
                                {"$": "Department of Surgery"},
                                {"$": "Dr Cipto Mangunkusumo National General Hospital"},
                                {"$": "University of Indonesia"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60069378",
                                    "@dptid": "100277495"
                                },
                                {"@afid": "60069377"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-6050126510e1c11650357753aadd431f-1",
                            "ce:source-text": "Department of Surgery, Dr Cipto Mangunkusumo National General Hospital, University of Indonesia, Jakarta, Indonesia",
                            "@dptid": "100277495"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "R. A.",
                                "ce:initials": "R.A.",
                                "ce:surname": "Syaiful",
                                "ce:indexed-name": "Syaiful R.A."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-afecb309798815685d140cb3d997c267-1",
                            "@seq": "22",
                            "ce:initials": "R.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Syaiful",
                            "@auid": "57214818481",
                            "ce:indexed-name": "Syaiful R.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "address-part": "Zhejiang",
                            "@afid": "60118432",
                            "@country": "chn",
                            "city": "Hangzhou",
                            "organization": [
                                {"$": "Department of Colorectal Surgery"},
                                {"$": "Second Affiliated Hospital"},
                                {"$": "Zhejiang University School of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60118432",
                                    "@dptid": "122951816"
                                },
                                {"@afid": "60029310"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-06a3e2a2a9dd506d1088b7fa79d4f023-1",
                            "ce:source-text": "Department of Colorectal Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China",
                            "@dptid": "122951816"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S. Z.",
                                "ce:initials": "S.Z.",
                                "ce:surname": "Zhang",
                                "ce:indexed-name": "Zhang S.Z."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-1f4dfcdd1fc3b5aecc3be19195f6ac3b-1",
                            "@seq": "23",
                            "ce:initials": "S.Z.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Zhang",
                            "@auid": "23391621200",
                            "ce:indexed-name": "Zhang S.Z."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "60030442",
                            "city": "Milan",
                            "organization": [
                                {"$": "Istituto Europeo di Oncologia"},
                                {"$": "IRCCS"}
                            ],
                            "affiliation-id": {"@afid": "60030442"},
                            "@affiliation-instance-id": "OB2BibRecID-948433298-67f5b398beddbe98e9599f876d7fb4bc-1",
                            "ce:source-text": "Istituto Europeo di Oncologia, IRCCS, Milan"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "G.",
                                "ce:initials": "G.",
                                "ce:surname": "Curigliano",
                                "ce:indexed-name": "Curigliano G."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-73d860a4614cf3aa1790b8ef0e1d2e4a-1",
                            "@seq": "24",
                            "ce:initials": "G.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Curigliano",
                            "@auid": "57221578995",
                            "ce:indexed-name": "Curigliano G."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60030318",
                            "@country": "ita",
                            "city": "Milan",
                            "organization": [
                                {"$": "Department of Oncology and Haematology"},
                                {"$": "University of Milano"}
                            ],
                            "affiliation-id": {
                                "@afid": "60030318",
                                "@dptid": "109081535"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-27617cd21122ebe939754709af019bf7-1",
                            "ce:source-text": "Department of Oncology and Haematology, University of Milano, Milan, Italy",
                            "@dptid": "109081535"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "G.",
                                "ce:initials": "G.",
                                "ce:surname": "Curigliano",
                                "ce:indexed-name": "Curigliano G."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-73d860a4614cf3aa1790b8ef0e1d2e4a-1",
                            "@seq": "24",
                            "ce:initials": "G.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Curigliano",
                            "@auid": "57221578995",
                            "ce:indexed-name": "Curigliano G."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "60028476",
                            "organization": [
                                {"$": "Division of Molecular Therapeutics"},
                                {"$": "Aichi Cancer Center Research Institute"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028476",
                                "@dptid": "121645162"
                            },
                            "state": "Nagoya",
                            "@affiliation-instance-id": "OB2BibRecID-948433298-6b9903cf558111e3b0e4a30db2253997-1",
                            "ce:source-text": "Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya",
                            "@dptid": "121645162"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "H.",
                                "ce:initials": "H.",
                                "ce:surname": "Ebi",
                                "ce:indexed-name": "Ebi H."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-d29deaf3c26bc1504f33045cfd6fc326-1",
                            "@seq": "27",
                            "ce:initials": "H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ebi",
                            "@auid": "6603124271",
                            "ce:indexed-name": "Ebi H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "@afid": "60012275",
                            "@country": "jpn",
                            "city": "Kawasaki",
                            "organization": [
                                {"$": "Department of Clinical Oncology"},
                                {"$": "St. Marianna University School of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60012275",
                                "@dptid": "109944289"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-9d6b5966a6fe45e8985796dbcd5c7b37-1",
                            "ce:source-text": "Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki",
                            "@dptid": "109944289"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "Y.",
                                "ce:initials": "Y.",
                                "ce:surname": "Sunakawa",
                                "ce:indexed-name": "Sunakawa Y."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-ea7ac535b09efc164a57802e21550f08-1",
                            "@seq": "28",
                            "ce:initials": "Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sunakawa",
                            "@auid": "23669095300",
                            "ce:indexed-name": "Sunakawa Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "60180317",
                            "city": "Sendai",
                            "organization": [
                                {"$": "Department of Clinical Oncology"},
                                {"$": "Tohoku University Graduate School of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60180317",
                                "@dptid": "125036219"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-3d8e4597bcbc00a6a7def49b13ba1336-1",
                            "ce:source-text": "Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Sendai",
                            "@dptid": "125036219"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "M.",
                                "ce:initials": "M.",
                                "ce:surname": "Takahashi",
                                "ce:indexed-name": "Takahashi M."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-da373fd77e6f6b9e14947cfc50e6718e-1",
                            "@seq": "29",
                            "ce:initials": "M.",
                            "@date-locked": "2023-08-08T18:26:41.927",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Takahashi",
                            "@auid": "55619302848",
                            "ce:indexed-name": "Takahashi M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "address-part": "Fukuoka",
                            "@afid": "60185923",
                            "@country": "jpn",
                            "organization": [
                                {"$": "Department of Oncology and Social Medicine"},
                                {"$": "Graduate School of Medical Sciences"},
                                {"$": "Kyushu University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60185923",
                                    "@dptid": "125086215"
                                },
                                {"@afid": "60011047"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-948433298-6dcd41cd91a021cd08535e68df107eb7-1",
                            "ce:source-text": "Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan",
                            "@dptid": "125086215"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "E.",
                                "ce:initials": "E.",
                                "ce:surname": "Baba",
                                "ce:indexed-name": "Baba E."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-b7fa9f401d7299413460a1d3377ad6d6-1",
                            "@seq": "30",
                            "ce:initials": "E.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Baba",
                            "@auid": "7005105717",
                            "ce:indexed-name": "Baba E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60023561",
                            "@country": "che",
                            "city": "Lausanne",
                            "organization": [
                                {"$": "Oncology Department"},
                                {"$": "Lausanne University Hospital (CHUV)"}
                            ],
                            "affiliation-id": {
                                "@afid": "60023561",
                                "@dptid": "113497458"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-57a2b6453179b80ebcb9e6e96dcdc1ba-1",
                            "ce:source-text": "Oncology Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland",
                            "@dptid": "113497458"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S.",
                                "ce:initials": "S.",
                                "ce:surname": "Peters",
                                "ce:indexed-name": "Peters S."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-e99f3a4ac0bff9f216152d9760d3da48-1",
                            "@seq": "31",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Peters",
                            "@auid": "57218315686",
                            "ce:indexed-name": "Peters S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "@afid": "60011374",
                            "@country": "jpn",
                            "city": "Sendai",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Tohoku University Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60011374",
                                "@dptid": "115381203"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-948433298-9374b36c3fd2f376ec6fcaef45eb1a76-1",
                            "ce:source-text": "Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan",
                            "@dptid": "115381203"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "C.",
                                "ce:initials": "C.",
                                "ce:surname": "Ishioka",
                                "ce:indexed-name": "Ishioka C."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-6dbeea8567ce30d327bb4707c79c217c-1",
                            "@seq": "32",
                            "ce:initials": "C.",
                            "@date-locked": "2023-07-24T04:09:22.095",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ishioka",
                            "@auid": "7005354286",
                            "ce:indexed-name": "Ishioka C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "postal-code": "ESMO",
                            "@country": "che",
                            "city": "Lugano",
                            "@affiliation-instance-id": "OB2BibRecID-948433298-8fe0b4045476d55c7b595e605fb43825-1",
                            "ce:source-text": "ESMO, Lugano, Switzerland"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "G.",
                                "ce:initials": "G.",
                                "ce:surname": "Pentheroudakis",
                                "ce:indexed-name": "Pentheroudakis G."
                            },
                            "@author-instance-id": "OB2BibRecID-948433298-e5ee6a7e76b93099d376716b8867df1d-1",
                            "@seq": "33",
                            "ce:initials": "G.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pentheroudakis",
                            "@auid": "56230606500",
                            "ce:indexed-name": "Pentheroudakis G."
                        }]
                    }
                ],
                "citation-title": "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer",
                "abstracts": "¬© 2023 The AuthorsThe European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer (mCRC), published in late 2022, were adapted in December 2022, according to previously established standard methodology, to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for the management of Asian patients with mCRC. The adapted guidelines presented in this manuscript represent the consensus opinions reached by a panel of Asian experts in the treatment of patients with mCRC representing the oncological societies of China (CSCO), Indonesia (ISHMO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO), co-ordinated by ESMO and the Japanese Society of Medical Oncology (JSMO). The voting was based on scientific evidence and was independent of the current treatment practices, drug access restrictions and reimbursement decisions in the different Asian countries. The latter are discussed separately in the manuscript. The aim is to provide guidance for the optimisation and harmonisation of the management of patients with mCRC across the different countries of Asia, drawing on the evidence provided by both Western and Asian trials, whilst respecting the differences in screening practices, molecular profiling and age and stage at presentation, coupled with a disparity in the drug approvals and reimbursement strategies, between the different countries.",
                "correspondence": {
                    "affiliation": {
                        "country": "Japan",
                        "address-part": "6-5-1, Kashiwanoha, Kashiwa-shi",
                        "postal-code": "277-8577",
                        "@country": "jpn",
                        "city": "Chiba",
                        "organization": [
                            {"$": "Department of Gastroenterology and Gastrointestinal Oncology"},
                            {"$": "National Cancer Center Hospital East"}
                        ],
                        "@affiliation-instance-id": "OB2BibRecID-948433298-81602e7f829b3e9b6bfbcc9e51c907e1-1"
                    },
                    "person": {
                        "@author-instance-id": "OB2BibRecID-948433298-f390bf9465dad74116284ee5e4e9a4f7-1",
                        "ce:initials": "T.",
                        "ce:surname": "Yoshino",
                        "ce:indexed-name": "Yoshino T."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "ESMO",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "guidelines",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "metastatic colorectal cancer",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Pan-Asian",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "treatment",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://www.journals.elsevier.com/esmo-open/",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "volisspag": {"voliss": {
                        "@volume": "8",
                        "@issue": "3"
                    }},
                    "@type": "j",
                    "sourcetitle": "ESMO Open",
                    "publicationdate": {
                        "month": "06",
                        "year": "2023",
                        "date-text": "June 2023",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "ESMO Open",
                    "@country": "gbr",
                    "issn": {
                        "$": "20597029",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Elsevier B.V."},
                    "article-number": "101558",
                    "@srcid": "21100873339"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "17",
                                    "classification-description": "Public Health, Social Medicine and Epidemiology"
                                },
                                {
                                    "classification-code": "36",
                                    "classification-description": "Health Policy, Economics and Management"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "tradenamegroup": {"tradenames": {
                        "trademanuitem": {"tradename": "s 1"},
                        "@type": "TNM"
                    }},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "845771-78-0"},
                                    {"$": "862111-32-8"}
                                ],
                                "chemical-name": "aflibercept"
                            },
                            {
                                "cas-registry-number": "166433-56-3",
                                "chemical-name": "anaplastic lymphoma kinase"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "216974-75-3"},
                                    {"$": "1438851-35-4"}
                                ],
                                "chemical-name": "bevacizumab"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "120168-50-5"},
                                    {"$": "606143-89-9"},
                                    {"$": "1073666-70-2"}
                                ],
                                "chemical-name": "binimetinib"
                            },
                            {
                                "cas-registry-number": "154361-50-9",
                                "chemical-name": "capecitabine"
                            },
                            {
                                "cas-registry-number": "205923-56-4",
                                "chemical-name": "cetuximab"
                            },
                            {
                                "cas-registry-number": "1269440-17-6",
                                "chemical-name": "encorafenib"
                            },
                            {
                                "cas-registry-number": "1108743-60-7",
                                "chemical-name": "entrectinib"
                            },
                            {
                                "cas-registry-number": "137632-09-8",
                                "chemical-name": "epidermal growth factor receptor 2"
                            },
                            {
                                "cas-registry-number": "51-21-8",
                                "chemical-name": "fluorouracil"
                            },
                            {
                                "cas-registry-number": "58-05-9",
                                "chemical-name": "folinic acid"
                            },
                            {
                                "cas-registry-number": "1194506-26-7",
                                "chemical-name": "fruquintinib"
                            },
                            {
                                "cas-registry-number": "150863-82-4",
                                "chemical-name": "gimeracil plus oteracil potassium plus tegafur"
                            },
                            {
                                "cas-registry-number": "477202-00-9",
                                "chemical-name": "ipilimumab"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "100286-90-6"},
                                    {"$": "97682-44-5"}
                                ],
                                "chemical-name": "irinotecan"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "231277-92-2"},
                                    {"$": "388082-78-8"},
                                    {"$": "437755-78-7"}
                                ],
                                "chemical-name": "lapatinib"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "1223403-58-4"},
                                    {"$": "1223405-08-0"}
                                ],
                                "chemical-name": "larotrectinib"
                            },
                            {
                                "cas-registry-number": "946414-94-4",
                                "chemical-name": "nivolumab"
                            },
                            {
                                "cas-registry-number": "61825-94-3",
                                "chemical-name": "oxaliplatin"
                            },
                            {
                                "cas-registry-number": "339177-26-3",
                                "chemical-name": "panitumumab"
                            },
                            {
                                "cas-registry-number": "1374853-91-4",
                                "chemical-name": "pembrolizumab"
                            },
                            {
                                "cas-registry-number": "947687-13-0",
                                "chemical-name": "ramucirumab"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "755037-03-7"},
                                    {"$": "1019206-88-2"}
                                ],
                                "chemical-name": "regorafenib"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "183204-74-2"},
                                    {"$": "183204-72-0"}
                                ],
                                "chemical-name": "tipiracil"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "180288-69-1"},
                                    {"$": "1446410-98-5"}
                                ],
                                "chemical-name": "trastuzumab"
                            },
                            {
                                "cas-registry-number": "70-00-8",
                                "chemical-name": "trifluridine"
                            },
                            {
                                "cas-registry-number": "937263-43-9",
                                "chemical-name": "tucatinib"
                            }
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors thank Ms K. Marinoni and Ms D. Young from the Scientific and Medical Division of ESMO, Ms Z. Othman Head of ESMO Asia Region Operations, and Ms Aries Low Senior Events Operations Coordinator, Asia Region Operations and the on-site team in Singapore for their assistance in the execution of the virtual/face-to-face meeting. A member of the ESMO Leaders Generation Programme, Associate Professor Rachel Wong, from Monash University, Australia, was present as an observer. Dr A. Kinsella of Cancer Communications and Consultancy Ltd, Cheshire, UK is acknowledged for her contribution to the preparation of the manuscript. Mrs N. Latino, ESMO Head of Scientific Affairs, is acknowledged for her contribution in confirming the ESMO-MCBSs. No external funding has been received for the preparation of these guidelines. Production costs have been covered by ESMO and JSMO from central funds. TY declares institutional grants from Amgen K.K. Nippon Boehringer Ingelheim, Chugai, Daiichi Sankyo, Eisai, FALCO Biosystems, Genomedia, Molecular Health GmbH, Merck Sharp & Dohme (MSD) K.K. Ono, Pfizer Japan, Roche Diagnostics K.K. Sanofi, K.K. and Taiho, and honoraria from Chugai, Merck Biopharma, MSD K.K. and Takeda. AC reports institutional funding as principal investigator (PI) from Actuate Therapeutic, Adaptimmune, Amcure, Amgen, Astellas, AstraZeneca, Bayer, BeiGene, Bristol Myers Squibb (BMS), FibroGen, Genentech, Lilly, MedImmune, Merck Serono, MSD, Natera, Novartis, Servier, Sierra Oncology, Takeda and Replimune; reports fees paid to his institution as an invited speaker from Amgen, Foundation Medicine, Merck Serono and Roche; fees paid to his institution for advisory board membership from Amgen, AnHeart Therapeutics, Merck Serono, Roche and Transgene; personal fees for editorial roles as an Associate Editor for Annals of Oncology and ESMO Open and as Editor for Cancer Treatment Reviews. He reports a non-remunerated role as General and Scientific Director of INCLIVA Biomedical Research Institute. HB declares honoraria from Ono Pharmaceuticals, Eli Lilly Japan and Taiho Pharmaceuticals. EM declares honoraria for lectures and presentations from Merck Serono, Pierre Fabre, Bayer, Servier, Incyte, Eisai and Roche and for educational events from ESMO, support for attending meetings from AstraZeneca and Pierre Fabre, for participation in advisory boards for Amgen and MSD and a data safety monitoring board for Roche. EO declares funding from Guardant Health and honoraria from Ono, Chugai, BMS, Eli Lilly, Bayer, Taiho and Takeda. R-HX declares honoraria from BMS, Merck Serono, Roche, Astellas, AstraZeneca, Hengrui Co. BeiGene and Junshi Co. NAM declares honoraria for presentations from AstraZeneca, Merck, Roche, MSD, Novartis and Pfizer, and for manuscript writing and educational events from AstraZeneca. MAL declares honoraria from Yuhan and participation in advisory boards for Roche, ElmediX, Servier, AstraZeneca, Yuhan and Green Cross. DC declares honoraria from Merck, support for attending meetings from Amgen, AstraZeneca and Ipsen Pharma and her role as treasurer of the Singapore Society of Oncology (SSO). LTC declares research funding from the Ministry of Science and Technology Taiwan, the Ministry of Health and Welfare Taiwan, Novartis, Pfizer, TTY, Polaris, Syncore, Celgene, Merck Serono and Ipsen, personal fees from Novartis, Eli Lilly, TTY, PharmaEngine, MSD, BMS, Ono, Syncore, AstraZeneca, Ipsen and Shire, and non-financial support in the provision of study medication from Novartis, TTY, BMS, Ono, Syncore, Celgene and Ipsen. ST declares honoraria from Merck, Roche, Amgen, BMS, Eisai, Taiho, Pfizer, AstraZeneca and Novartis, support for attending meetings from Eisai and Roche, and a patent with AstraZeneca. KHY declares moderator or expert honoraria from TTY, Amgen, Roche, Ono, BMS, MSD, Pfizer, Daiichi-Sankyo, Novartis, Bayer, CStone and Merck. MDS declares a Philippine General Hospital Research grant, honoraria from Abbott Pils and Fresenius Kabi, support for attending meetings from Abbott, Philippine General Hospital and UP Manila, and membership of the board of the ERAS Society Philippines. WJSW declares honoraria from Merck. RTC declares honoraria from Eli Lilly, Roche and AstraZeneca. GCur declares consulting fees from BMS, Roche, Pfizer, Eli Lilly, AstraZeneca, Daiichi-Sankyo, Merck, Seagen and Ellipsis, honoraria from Pfizer, Eli Lilly and Relay, and support for attending meetings from Daiichi-Sankyo, all outside of the submitted work. SM reports research funding from Roche Diagnostics and honoraria from Roche diagnostics and Merck Serono Biopharma. YN reports research funding from Chugai, Daiichi-Sankyo, Genomedia, Guardant Health, Roche Diagnostics, Seagen and Taiho, and honoraria from Chugai, Guardant Health AMEA and Merck Biopharma. HE reports personal honoraria from Amgen, Merck Serono, Takeda, Chugai Pharmaceuticals, Incyte, BMS, Kyowa-Kirin and AstraZeneca. YS reports research funding from Chugai, Taiho, Takeda, Sanofi, Otsuka Pharmaceuticals and Eli Lilly Japan, honoraria from Eli Lilly Japan, BMS, Chugai, Takeda, Ono, Merck Biopharma, Taiho, Bayer, Daiichi-Sankyo, MSD, Sysmex and Guardant Health and participation in advisory boards for Merck Biopharma, Ono and Guardant Health. MT reports research funding from Ono Pharmaceuticals and honoraria from Ono Pharmaceuticals, BMS, Daiichi-Sankyo and Taiho pharmaceuticals. EB declares grants from Taiho, Chugai and Eli Lilly, honoraria from Taiho, Chugai, Ono, Merck, Daiichi-Sankyo, Eli Lilly, MSD, BMS, Novartis, Janssen, Takeda, Tsumura and Bayer and participation in independent data monitoring committees for Daiichi-Sankyo, Astellas and AstraZeneca. SP declares fees for consultancy/advisory roles from AbbVie, Amgen, Arcus, AstraZeneca, Bayer, BeiGene, BioInvent, Biocartis, Blueprint Medicines, Boehringer Ingelheim, BMS, Daiichi Sankyo, Debiopharm, ecancer, Eli Lilly, Elsevier, F-star, Foundation Medicine, Genzyme, Gilead, GlaxoSmithKline (GSK), Illumina, Incyte, IQVIA, iTHeos, Janssen, Medscape, MSD, Merck Serono, Mirati, Novartis, Novocure, PharmaMar, Phosplatin Therapeutics, Pfizer, Regeneron, Roche/Genentech, Sanofi, Seagen, Takeda, Vaccibody, speaker roles for AstraZeneca, Boehringer Ingelheim, BMS, ecancer, Eli Lilly, Fishawack, Illumina, Imedex, Medscape, Mirati, MSD, Novartis, Oncology Education, PER, Pfizer, PRIME, RMEI, Roche/Genentech, RTP, Sanofi, Takeda and steering committee and trial chair roles as follows: AstraZeneca, Coordinating PI, institutional, no financial interest, MERMAID-1; AstraZeneca, steering committee member, institutional, no financial interest, MERMAID-2, POSEIDON, MYSTIC; BeiGene, steering committee member, institutional, no financial interest, BGB-A317-A1217-301/AdvanTIG-301; BMS, steering committee member, institutional, no financial interest, clinical trial steering committee CheckMate 743, CheckMate 73L, CheckMate 331 and 451; BMS, steering committee member, institutional, no financial interest, RELATIVITY 095; GSK, trial chair, institutional, no financial interest, clinical trial chair ZEAL-1; iTeos, steering committee member, institutional, no financial interest, phase 2 inupadenant with chemotherapy; Mirati, steering committee member, institutional, no financial interest, clinical trial steering committee SAPPHIRE; MSD, steering committee member, institutional, no financial interest, clinical trial steering committee PEARLS, MK-7684A; Pharma Mar, steering committee member, institutional, no financial interest, LAGOON; Phosplatin Therapeutics, steering committee member, institutional, no financial interest, phase 1/2 trials; Roche/Genentech, trial chair, institutional, no financial interest, clinical trial chair Skyscraper-01; chair ALEX; steering committee BFAST; steering committee BEAT-Meso; steering committee ImPower-030, IMforte. Also role as ESMO president, ETOP/EORTC/SAKK PI, involved in academic trials, ETOP/IBCSG partners\u2019 officer. Council member and scientific chair, SAKK, vice-president Lung Group, SAMO, vice president. CI has received research funding from Chugai, Taiho, Asahi Kasei Pharma, Daiichi-Sankyo, Takeda, Shionogi, Novartis, Eisai, Sanofi K.K., Yakult Honsha, Tsumura, Merck Biopharma, Incyte Bioscience Japan, AstraZeneca K.K. Hitachi, Riken Genesis, Ono, Otsuka Pharmaceuticals, Kyowa-Kirin, Nippon-Kayaku, Eli Lilly Japan, Ascent Development Services, Janssen K.K. Hitachi, Bayer Yakuhin and Nippon Boehringer Ingelheim, honoraria from Daiichi-Sankyo, Taiho, Merck Biopharma, Sanofi K.K., Eli Lilly Japan K.K. Chugai, BMS K.K. Terumo Coporation, Asahi Kasei, Nippon Kayaku, Ono, Takeda, Nihon Servier, Bayer Yakuhin, M3 Inc. Incyte Biosciences, Novartis Pharma K.K. Kyowa Kirin, payment for expert testimony from Chugai, Pfizer Japan Inc. and BMS K.K. and an unpaid role with Tohu Clinical Oncology Research and Education Society. All other authors have declared no conflicts of interest.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-acronym": "Abbvie",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "AbbVie"
                            },
                            "grant-agency-id": "100006483"
                        },
                        {
                            "grant-acronym": "Astellas",
                            "grant-agency": {
                                "@iso-code": "can",
                                "$": "Astellas Pharma Canada"
                            },
                            "grant-agency-id": "100012317"
                        },
                        {
                            "grant-acronym": "Astellas",
                            "grant-agency": {
                                "@iso-code": "can",
                                "$": "Astellas Pharma Canada"
                            },
                            "grant-agency-id": "100012317"
                        },
                        {
                            "grant-acronym": "Astellas",
                            "grant-agency": {
                                "@iso-code": "can",
                                "$": "Astellas Pharma Canada"
                            },
                            "grant-agency-id": "100012317"
                        },
                        {
                            "grant-acronym": "BMS",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Bristol-Myers Squibb"
                            },
                            "grant-agency-id": "100002491"
                        },
                        {
                            "grant-acronym": "GSK",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "GlaxoSmithKline"
                            },
                            "grant-agency-id": "100004330"
                        },
                        {
                            "grant-acronym": "KKD",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Kyowa Kirin Pharmaceutical Development"
                            },
                            "grant-agency-id": "100016348"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-acronym": "Yakult",
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Yakult Honsha"
                            },
                            "grant-agency-id": "501100012030"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Bayer"
                            },
                            "grant-agency-id": "100004326"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Bayer"
                            },
                            "grant-agency-id": "100004326"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Bayer"
                            },
                            "grant-agency-id": "100004326"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Bayer"
                            },
                            "grant-agency-id": "100004326"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Bayer"
                            },
                            "grant-agency-id": "100004326"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Bayer Yakuhin"
                            },
                            "grant-agency-id": "100015731"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Bayer Yakuhin"
                            },
                            "grant-agency-id": "100015731"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Celgene"
                            },
                            "grant-agency-id": "100006436"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Daiichi-Sankyo"
                            },
                            "grant-agency-id": "501100002973"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eisai"
                            },
                            "grant-agency-id": "501100003769"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eisai"
                            },
                            "grant-agency-id": "501100003769"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eisai"
                            },
                            "grant-agency-id": "501100003769"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eisai"
                            },
                            "grant-agency-id": "501100003769"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eli Lilly Japan"
                            },
                            "grant-agency-id": "100014422"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eli Lilly Japan"
                            },
                            "grant-agency-id": "100014422"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eli Lilly Japan"
                            },
                            "grant-agency-id": "100014422"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eli Lilly Japan"
                            },
                            "grant-agency-id": "100014422"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Eli Lilly Japan"
                            },
                            "grant-agency-id": "100014422"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "FibroGen"
                            },
                            "grant-agency-id": "100006591"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Genentech"
                            },
                            "grant-agency-id": "100004328"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Genentech"
                            },
                            "grant-agency-id": "100004328"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Genentech"
                            },
                            "grant-agency-id": "100004328"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Genentech"
                            },
                            "grant-agency-id": "100004328"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Genzyme"
                            },
                            "grant-agency-id": "100004329"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Hitachi"
                            },
                            "grant-agency-id": "100008238"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Hitachi"
                            },
                            "grant-agency-id": "100008238"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Illumina"
                            },
                            "grant-agency-id": "100010905"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Illumina"
                            },
                            "grant-agency-id": "100010905"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Imedex"
                            },
                            "grant-agency-id": "100006972"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Ipsen"
                            },
                            "grant-agency-id": "501100014382"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Ipsen"
                            },
                            "grant-agency-id": "501100014382"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Ipsen"
                            },
                            "grant-agency-id": "501100014382"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Les Laboratories Pierre Fabre"
                            },
                            "grant-agency-id": "100013226"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Les Laboratories Pierre Fabre"
                            },
                            "grant-agency-id": "100013226"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "MedImmune"
                            },
                            "grant-agency-id": "501100004628"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Novartis Pharma"
                            },
                            "grant-agency-id": "100008792"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Novocure"
                            },
                            "grant-agency-id": "100012634"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Pfizer Japan"
                            },
                            "grant-agency-id": "100010793"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Pfizer Japan"
                            },
                            "grant-agency-id": "100010793"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "esp",
                                "$": "PharmaMar"
                            },
                            "grant-agency-id": "501100013119"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Roche Diagnostics"
                            },
                            "grant-agency-id": "100016545"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Roche Diagnostics"
                            },
                            "grant-agency-id": "100016545"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Roche Diagnostics"
                            },
                            "grant-agency-id": "100016545"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Sanofi"
                            },
                            "grant-agency-id": "100004339"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Sanofi"
                            },
                            "grant-agency-id": "100004339"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Sanofi"
                            },
                            "grant-agency-id": "100004339"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Sanofi"
                            },
                            "grant-agency-id": "100004339"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Sanofi K.K."
                            },
                            "grant-agency-id": "100015990"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Sanofi K.K."
                            },
                            "grant-agency-id": "100015990"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Servier"
                            },
                            "grant-agency-id": "501100011725"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Servier"
                            },
                            "grant-agency-id": "501100011725"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Servier"
                            },
                            "grant-agency-id": "501100011725"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "fra",
                                "$": "Servier"
                            },
                            "grant-agency-id": "501100011725"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Shionogi"
                            },
                            "grant-agency-id": "501100005612"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Terumo"
                            },
                            "grant-agency-id": "501100008645"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "16",
                    "@timestamp": "BST 13:34:02",
                    "@year": "2023",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2024683838",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "948433298",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230499821",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "37236086",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20231476303",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20231973927",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85160253356",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85160253356",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "641429198",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "911675116",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S2059702923007846",
                    "ce:ern": "pii:S2059702923007846",
                    "ce:doi": "10.1016/j.esmoop.2023.101558"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "106",
                "reference": [
                    {
                        "ref-fulltext": "Sung, H., Ferlay, J., Siegel, R.L., et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:3 (2021), 209\u2013249.",
                        "@reference-instance-id": "OB2BibRecID-948433298-83af2e446e2877667cffdff36b682e23-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100345654",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "249"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Sung",
                                        "ce:indexed-name": "Sung H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferlay",
                                        "ce:indexed-name": "Ferlay J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Siegel",
                                        "ce:indexed-name": "Siegel R.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249."
                    },
                    {
                        "ref-fulltext": "Wong, M.C., Ding, H., Wang, J., et al. Prevalence and risk factors of colorectal cancer in Asia. Intest Res 17:3 (2019), 317\u2013329.",
                        "@reference-instance-id": "OB2BibRecID-948433298-6a17f2696745e4160a32d99426bdae62-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Prevalence and risk factors of colorectal cancer in Asia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85099812217",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "317",
                                    "@last": "329"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong M.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Ding",
                                        "ce:indexed-name": "Ding H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Intest Res"
                        },
                        "ce:source-text": "Wong MC, Ding H, Wang J, et al. Prevalence and risk factors of colorectal cancer in Asia. Intest Res. 2019;17(3):317-329."
                    },
                    {
                        "ref-fulltext": "Onyoh, E.F., Hsu, W.F., Chang, L.C., et al. The rise of colorectal cancer in Asia: epidemiology, screening, and management. Curr Gastroenterol Rep, 21(8), 2019, 36.",
                        "@reference-instance-id": "OB2BibRecID-948433298-910077a95dc366adc7407c5d6408b947-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The rise of colorectal cancer in Asia: epidemiology, screening, and management"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85068757351",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "8"
                                },
                                "pagerange": {"@first": "36"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Onyoh",
                                        "ce:indexed-name": "Onyoh E.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Hsu",
                                        "ce:indexed-name": "Hsu W.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Chang",
                                        "ce:indexed-name": "Chang L.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Curr Gastroenterol Rep"
                        },
                        "ce:source-text": "Onyoh EF, Hsu WF, Chang LC, et al. The rise of colorectal cancer in Asia: epidemiology, screening, and management. Curr Gastroenterol Rep. 2019;21(8):36."
                    },
                    {
                        "ref-fulltext": "Arnold, M., Sierra, M.S., Laversanne, M., et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:4 (2017), 683\u2013691.",
                        "@reference-instance-id": "OB2BibRecID-948433298-e832996d4da008f0e249c6cde185f209-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Global patterns and trends in colorectal cancer incidence and mortality"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84962150091",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "66",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "683",
                                    "@last": "691"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Arnold",
                                        "ce:indexed-name": "Arnold M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Sierra",
                                        "ce:indexed-name": "Sierra M.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Laversanne",
                                        "ce:indexed-name": "Laversanne M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683-691."
                    },
                    {
                        "ref-fulltext": "Chiu, H.M., Jen, G.H., Wang, Y.W., et al. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers. Gut 70:12 (2021), 2321\u20132329.",
                        "@reference-instance-id": "OB2BibRecID-948433298-2d2ad4026beb7d37acc47078c97610fc-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100191017",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "70",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "2321",
                                    "@last": "2329"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Chiu",
                                        "ce:indexed-name": "Chiu H.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Jen",
                                        "ce:indexed-name": "Jen G.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang Y.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Chiu HM, Jen GH, Wang YW, et al. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers. Gut. 2021;70(12):2321-2329."
                    },
                    {
                        "ref-fulltext": "Wang, Y.W., Chen, H.H., Wu, M.S., et al. Current status and future challenge of population-based organized colorectal cancer screening: lesson from the first decade of Taiwanese program. J Formos Med Assoc 117:5 (2018), 358\u2013364.",
                        "@reference-instance-id": "OB2BibRecID-948433298-3245bf12a003f15e60b5954970d6fe30-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Current status and future challenge of population-based organized colorectal cancer screening: lesson from the first decade of Taiwanese program"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85030556997",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "117",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "358",
                                    "@last": "364"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang Y.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen H.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu M.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Formos Med Assoc"
                        },
                        "ce:source-text": "Wang YW, Chen HH, Wu MS, et al Current status and future challenge of population-based organized colorectal cancer screening: lesson from the first decade of Taiwanese program. J Formos Med Assoc. 2018;117(5):358-364."
                    },
                    {
                        "ref-fulltext": "Park, B., Lee, Y.Y., Song, S.Y., et al. Trends of colorectal cancer screening rates in Korea: Korean National Cancer Screening Survey 2005-2020. Gut Liver 16:6 (2022), 930\u2013941.",
                        "@reference-instance-id": "OB2BibRecID-948433298-f956b3dd694623461d8b13ea6185db4f-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Trends of colorectal cancer screening rates in Korea: Korean National Cancer Screening Survey 2005-2020"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85140623411",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "930",
                                    "@last": "941"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee Y.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Song",
                                        "ce:indexed-name": "Song S.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut Liver"
                        },
                        "ce:source-text": "Park B, Lee YY, Song SY, et al. Trends of colorectal cancer screening rates in Korea: Korean National Cancer Screening Survey 2005-2020. Gut Liver. 2022;16(6):930-941."
                    },
                    {
                        "ref-fulltext": "Sano, Y., Byeon, J.S., Li, X.B., et al. Colorectal cancer screening of the general population in East Asia. Dig Endosc 28:3 (2016), 243\u2013249.",
                        "@reference-instance-id": "OB2BibRecID-948433298-d7d360a329c022906581db39ac65cd3a-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Colorectal cancer screening of the general population in East Asia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84961742850",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "243",
                                    "@last": "249"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Sano",
                                        "ce:indexed-name": "Sano Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Byeon",
                                        "ce:indexed-name": "Byeon J.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "X.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li X.B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Dig Endosc"
                        },
                        "ce:source-text": "Sano Y, Byeon JS, Li XB, et al. Colorectal cancer screening of the general population in East Asia. Dig Endosc. 2016;28(3):243-249."
                    },
                    {
                        "ref-fulltext": "Singapore national screening programme. Available at https://www.healthhub.sg/programmes/61/Screen_for_Life. (Accessed 20 February 2023)",
                        "@reference-instance-id": "OB2BibRecID-948433298-67db3bc3ac6479e3a092377ab9a5354e-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.healthhub.sg/programmes/61/Screen_for_Life",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Singapore national screening programme"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85167843217",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Available at (Accessed 20 February 2023)"
                        },
                        "ce:source-text": "Singapore national screening programme. Available at https://www.healthhub.sg/programmes/61/Screen_for_Life. Accessed February 20, 2023."
                    },
                    {
                        "ref-fulltext": "Sung, J.J.Y., Chiu, H.M., Lieberman, D., et al. Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance. Gut 71:11 (2022), 2152\u20132166.",
                        "@reference-instance-id": "OB2BibRecID-948433298-981d979461198e1ea8ff41c7c5b4130b-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85139570564",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "2152",
                                    "@last": "2166"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Sung",
                                        "ce:indexed-name": "Sung J.J.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Chiu",
                                        "ce:indexed-name": "Chiu H.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Lieberman",
                                        "ce:indexed-name": "Lieberman D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "Sung JJY, Chiu HM, Lieberman D, et al. Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance. Gut. 2022;71(11):2152-2166."
                    },
                    {
                        "ref-fulltext": "Zhou, H., Shen, Z., Zhao, J., et al. [Distribution characteristics and risk factors of colorectal adenomas]. Zhonghua Wei Chang Wai Ke Za Zhi 21:6 (2018), 678\u2013684.",
                        "@reference-instance-id": "OB2BibRecID-948433298-bd727250009b58d522ee83dd4c29dcce-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "[Distribution characteristics and risk factors of colorectal adenomas]"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055071824",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "678",
                                    "@last": "684"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Shen",
                                        "ce:indexed-name": "Shen Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhao",
                                        "ce:indexed-name": "Zhao J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Zhonghua Wei Chang Wai Ke Za Zhi"
                        },
                        "ce:source-text": "Zhou H, Shen Z, Zhao J, et al. [Distribution characteristics and risk factors of colorectal adenomas]. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(6):678-684."
                    },
                    {
                        "ref-fulltext": "Lee, S.Y., Song, W.H., Oh, S.C., et al. Anatomical distribution and detection rate of colorectal neoplasms according to age in the colonoscopic screening of a Korean population. Ann Surg Treat Res 94:1 (2018), 36\u201343.",
                        "@reference-instance-id": "OB2BibRecID-948433298-bb936418e82760812facd312924d7384-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Anatomical distribution and detection rate of colorectal neoplasms according to age in the colonoscopic screening of a Korean population"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040743470",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "94",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "36",
                                    "@last": "43"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee S.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Song",
                                        "ce:indexed-name": "Song W.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Oh",
                                        "ce:indexed-name": "Oh S.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Surg Treat Res"
                        },
                        "ce:source-text": "Lee SY, Song WH, Oh SC, et al. Anatomical distribution and detection rate of colorectal neoplasms according to age in the colonoscopic screening of a Korean population. Ann Surg Treat Res. 2018;94(1):36-43."
                    },
                    {
                        "ref-fulltext": "Sung, J.J.Y., Chiu, H.M., Jung, K.W., et al. Increasing trend in young-onset colorectal cancer in Asia: more cancers in men and more rectal cancers. Am J Gastroenterol 114:2 (2019), 322\u2013329.",
                        "@reference-instance-id": "OB2BibRecID-948433298-259f659df10a3109e8598590e039a770-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Increasing trend in young-onset colorectal cancer in Asia: more cancers in men and more rectal cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85061126666",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "114",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "322",
                                    "@last": "329"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Sung",
                                        "ce:indexed-name": "Sung J.J.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Chiu",
                                        "ce:indexed-name": "Chiu H.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Jung",
                                        "ce:indexed-name": "Jung K.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "Sung JJY, Chiu HM, Jung KW, et al. Increasing trend in young-onset colorectal cancer in Asia: more cancers in men and more rectal cancers. Am J Gastroenterol. 2019;114(2):322-329."
                    },
                    {
                        "ref-fulltext": "Cervantes, A., Adam, R., Rosello, S., et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 34:1 (2023), 10\u201332.",
                        "@reference-instance-id": "OB2BibRecID-948433298-11cfa7a81b0b5ef53d3f133d8cbb6d2c-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142427456",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "34",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "10",
                                    "@last": "32"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cervantes",
                                        "ce:indexed-name": "Cervantes A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Adam",
                                        "ce:indexed-name": "Adam R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Rosello",
                                        "ce:indexed-name": "Rosello S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Cervantes A, Adam R, Rosello S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10-32."
                    },
                    {
                        "ref-fulltext": "Amado, R.G., Wolf, M., Peeters, M., et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 26:10 (2008), 1626\u20131634.",
                        "@reference-instance-id": "OB2BibRecID-948433298-03baad57b5d2091de27770271c9e3931-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "42649145667",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1626",
                                    "@last": "1634"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Amado",
                                        "ce:indexed-name": "Amado R.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Wolf",
                                        "ce:indexed-name": "Wolf M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Peeters",
                                        "ce:indexed-name": "Peeters M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(10):1626-1634."
                    },
                    {
                        "ref-fulltext": "Douillard, J.-Y., Siena, S., Cassidy, J., et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol 28:31 (2010), 4697\u20134705.",
                        "@reference-instance-id": "OB2BibRecID-948433298-59bbb26197d9df6365dc5b85284dd4d9-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78149250536",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "31"
                                },
                                "pagerange": {
                                    "@first": "4697",
                                    "@last": "4705"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.-Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Douillard",
                                        "ce:indexed-name": "Douillard J.-Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Siena",
                                        "ce:indexed-name": "Siena S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cassidy",
                                        "ce:indexed-name": "Cassidy J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Douillard J-Y, Siena S, Cassidy J, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010;28(31):4697-4705."
                    },
                    {
                        "ref-fulltext": "Karapetis, C.S., Khambata-Ford, S., Jonker, D.J., et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359:17 (2008), 1757\u20131765.",
                        "@reference-instance-id": "OB2BibRecID-948433298-eb276506c8afc5d04fe2cc136c754a59-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "K-ras mutations and benefit from cetuximab in advanced colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "54949085398",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "359",
                                    "@issue": "17"
                                },
                                "pagerange": {
                                    "@first": "1757",
                                    "@last": "1765"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Karapetis",
                                        "ce:indexed-name": "Karapetis C.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Khambata-Ford",
                                        "ce:indexed-name": "Khambata-Ford S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Jonker",
                                        "ce:indexed-name": "Jonker D.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359(17):1757-1765."
                    },
                    {
                        "ref-fulltext": "Schirripa, M., Biason, P., Lonardi, S., et al. Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: a detailed clinical, pathologic, and molecular characterization. Clin Cancer Res 25:13 (2019), 3954\u20133961.",
                        "@reference-instance-id": "OB2BibRecID-948433298-bd96d0708a59199a70c09896ac06324f-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: a detailed clinical, pathologic, and molecular characterization"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066971663",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "3954",
                                    "@last": "3961"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Schirripa",
                                        "ce:indexed-name": "Schirripa M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Biason",
                                        "ce:indexed-name": "Biason P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lonardi",
                                        "ce:indexed-name": "Lonardi S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Schirripa M, Biason P, Lonardi S, et al. Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: a detailed clinical, pathologic, and molecular characterization. Clin Cancer Res. 2019;25(13):3954-3961."
                    },
                    {
                        "ref-fulltext": "Kopetz, S., Grothey, A., Yaeger, R., et al. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. N Engl J Med 381:17 (2019), 1632\u20131643.",
                        "@reference-instance-id": "OB2BibRecID-948433298-0bd15d16cde9879e31d553c8c838d3f8-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073505156",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "381",
                                    "@issue": "17"
                                },
                                "pagerange": {
                                    "@first": "1632",
                                    "@last": "1643"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kopetz",
                                        "ce:indexed-name": "Kopetz S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Grothey",
                                        "ce:indexed-name": "Grothey A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Yaeger",
                                        "ce:indexed-name": "Yaeger R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Kopetz S, Grothey A, Yaeger R, et al. Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. N Engl J Med. 2019;381(17):1632-1643."
                    },
                    {
                        "ref-fulltext": "Andr√©, T., Shiu, K.-K., Kim, T.W., et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med 383:23 (2020), 2207\u20132218.",
                        "@reference-instance-id": "OB2BibRecID-948433298-b6efbc08d83c7b1e29d8df9ab0032119-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Pembrolizumab in microsatellite-instability-high advanced colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85097123112",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "383",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "2207",
                                    "@last": "2218"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Andr√©",
                                        "ce:indexed-name": "Andre T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.-K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shiu",
                                        "ce:indexed-name": "Shiu K.-K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Andre T, Shiu K-K, Kim TW, et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med. 2020;383(23):2207-2218."
                    },
                    {
                        "ref-fulltext": "Le, D.T., Uram, J.N., Wang, H., et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:26 (2015), 2509\u20132520.",
                        "@reference-instance-id": "OB2BibRecID-948433298-bcc51a6dc397fde0f868bd40bec6ee72-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "PD-1 blockade in tumors with mismatch-repair deficiency"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84932628341",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "372",
                                    "@issue": "26"
                                },
                                "pagerange": {
                                    "@first": "2509",
                                    "@last": "2520"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Le",
                                        "ce:indexed-name": "Le D.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Uram",
                                        "ce:indexed-name": "Uram J.N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509-2520."
                    },
                    {
                        "ref-fulltext": "Sartore-Bianchi, A., Trusolino, L., Martino, C., et al. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Lancet Oncol 17:6 (2016), 738\u2013746.",
                        "@reference-instance-id": "OB2BibRecID-948433298-10f4ddab5e69939b9f8fb0d24ac9c1f9-22",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84963976837",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "738",
                                    "@last": "746"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sartore-Bianchi",
                                        "ce:indexed-name": "Sartore-Bianchi A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Trusolino",
                                        "ce:indexed-name": "Trusolino L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Martino",
                                        "ce:indexed-name": "Martino C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Sartore-Bianchi A, Trusolino L, Martino C, et al. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016;17(6):738-746."
                    },
                    {
                        "ref-fulltext": "Pietrantonio, F., Di Nicolantonio, F., Schrock, A.B., et al. ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer. J Natl Cancer Inst, 109(12), 2017.",
                        "@reference-instance-id": "OB2BibRecID-948433298-9842d195b8c4f729f3b064f48ddbf489-23",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85042155645",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "109",
                                "@issue": "12"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Pietrantonio",
                                        "ce:indexed-name": "Pietrantonio F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Di Nicolantonio",
                                        "ce:indexed-name": "Di Nicolantonio F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Schrock",
                                        "ce:indexed-name": "Schrock A.B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Cancer Inst"
                        },
                        "ce:source-text": "Pietrantonio F, Di Nicolantonio F, Schrock AB, et al. ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer. J Natl Cancer Inst. 2017;109(12)."
                    },
                    {
                        "ref-fulltext": "Doebele, R.C., Drilon, A., Paz-Ares, L., et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncol 21:2 (2020), 271\u2013282.",
                        "@reference-instance-id": "OB2BibRecID-948433298-9a5549a1f90323eacb91b166c5fa487f-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078321993",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "271",
                                    "@last": "282"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Doebele",
                                        "ce:indexed-name": "Doebele R.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Drilon",
                                        "ce:indexed-name": "Drilon A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Paz-Ares",
                                        "ce:indexed-name": "Paz-Ares L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Doebele RC, Drilon A, Paz-Ares L, et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncol. 2020;21(2):271-282."
                    },
                    {
                        "ref-fulltext": "Hong, D.S., DuBois, S.G., Kummar, S., et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. Lancet Oncol 21:4 (2020), 531\u2013540.",
                        "@reference-instance-id": "OB2BibRecID-948433298-688fe3cd5021ced89999f2cf6db38787-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85082428468",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "531",
                                    "@last": "540"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hong",
                                        "ce:indexed-name": "Hong D.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.G.",
                                        "@_fa": "true",
                                        "ce:surname": "DuBois",
                                        "ce:indexed-name": "DuBois S.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kummar",
                                        "ce:indexed-name": "Kummar S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Hong DS, DuBois SG, Kummar S, et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. Lancet Oncol. 2020;21(4):531-540."
                    },
                    {
                        "ref-fulltext": "Marchi√≤, C., Scaltriti, M., Ladanyi, M., et al. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Ann Oncol 30:9 (2019), 1417\u20131427.",
                        "@reference-instance-id": "OB2BibRecID-948433298-adcab9c1d0bcba46ec96b21c44ac09e9-26",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85072662511",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1417",
                                    "@last": "1427"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Marchi√≤",
                                        "ce:indexed-name": "Marchio C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Scaltriti",
                                        "ce:indexed-name": "Scaltriti M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Ladanyi",
                                        "ce:indexed-name": "Ladanyi M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Marchio C, Scaltriti M, Ladanyi M, et al. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Ann Oncol. 2019;30(9):1417-1427."
                    },
                    {
                        "ref-fulltext": "Yoshino, T., Argiles, G., Oki, E., et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer. Ann Oncol 32:12 (2021), 1496\u20131510.",
                        "@reference-instance-id": "OB2BibRecID-948433298-48cafce92691e33c43549f9afb9a6b31-27",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85114671002",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1496",
                                    "@last": "1510"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Argiles",
                                        "ce:indexed-name": "Argiles G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Oki",
                                        "ce:indexed-name": "Oki E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Yoshino T, Argiles G, Oki E, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer. Ann Oncol. 2021;32(12):1496-1510."
                    },
                    {
                        "ref-fulltext": "Niekel, M.C., Bipat, S., Stoker, J., Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:3 (2010), 674\u2013684.",
                        "@reference-instance-id": "OB2BibRecID-948433298-c40c9777c6821abaf50fc6cb7b154c3c-28",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78649643868",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "257",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "674",
                                    "@last": "684"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Niekel",
                                    "ce:indexed-name": "Niekel M.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Bipat",
                                    "ce:indexed-name": "Bipat S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Stoker",
                                    "ce:indexed-name": "Stoker J."
                                }
                            ]},
                            "ref-sourcetitle": "Radiology"
                        },
                        "ce:source-text": "Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology. 2010;257(3):674-684."
                    },
                    {
                        "ref-fulltext": "Kanemitsu, Y., Shitara, K., Mizusawa, J., et al. Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial. J. Clin Oncol 39:10 (2021), 1098\u20131107.",
                        "@reference-instance-id": "OB2BibRecID-948433298-0b4cf49a76ec60b7d55778fea7ed399d-29",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial. J"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85103682174",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "39",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1098",
                                    "@last": "1107"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kanemitsu",
                                        "ce:indexed-name": "Kanemitsu Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shitara",
                                        "ce:indexed-name": "Shitara K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Mizusawa",
                                        "ce:indexed-name": "Mizusawa J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Oncol"
                        },
                        "ce:source-text": "Kanemitsu Y, Shitara K, Mizusawa J, et al. Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial. J Clin Oncol. 2021;39(10):1098-1107."
                    },
                    {
                        "ref-fulltext": "Rahbari, N.N., Biondo, S., Fei√üt, M., et al. Randomized clinical trial on resection of the primary tumor versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases. J Clin Oncol, 40, 2022, LBA3507.",
                        "@reference-instance-id": "OB2BibRecID-948433298-bc6a2c7fce81c319127ca5b8a98ab4c5-30",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Randomized clinical trial on resection of the primary tumor versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85164543986",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {"@first": "LBA3507"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Rahbari",
                                        "ce:indexed-name": "Rahbari N.N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Biondo",
                                        "ce:indexed-name": "Biondo S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fei√üt",
                                        "ce:indexed-name": "Feisst M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Rahbari NN, Biondo S, Feisst M, et al. Randomized clinical trial on resection of the primary tumor versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases. J Clin Oncol. 2022;40:LBA3507."
                    },
                    {
                        "ref-fulltext": "Elias, D., De Baere, T., Smayra, T., et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 89:6 (2002), 752\u2013756.",
                        "@reference-instance-id": "OB2BibRecID-948433298-b212243d655e8ee6b79c7f2417d64d32-31",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib31",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0036276209",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "89",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "752",
                                    "@last": "756"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Elias",
                                        "ce:indexed-name": "Elias D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "De Baere",
                                        "ce:indexed-name": "De Baere T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Smayra",
                                        "ce:indexed-name": "Smayra T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Surg"
                        },
                        "ce:source-text": "Elias D, De Baere T, Smayra T, et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg. 2002;89(6):752-756."
                    },
                    {
                        "ref-fulltext": "Gu, Y., Huang, Z., Gu, H., et al. Does the site of the primary affect outcomes when ablating colorectal liver metastases with radiofrequency ablation?. Cardiovasc Intervent Radiol 41:6 (2018), 912\u2013919.",
                        "@reference-instance-id": "OB2BibRecID-948433298-f15373b30189a2f6bf72ec65a0819be8-32",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Does the site of the primary affect outcomes when ablating colorectal liver metastases with radiofrequency ablation?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib32",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85044476815",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "41",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "912",
                                    "@last": "919"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Gu",
                                        "ce:indexed-name": "Gu Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Gu",
                                        "ce:indexed-name": "Gu H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cardiovasc Intervent Radiol"
                        },
                        "ce:source-text": "Gu Y, Huang Z, Gu H, et al. Does the site of the primary affect outcomes when ablating colorectal liver metastases with radiofrequency ablation? Cardiovasc Intervent Radiol. 2018;41(6):912-919."
                    },
                    {
                        "ref-fulltext": "Sofocleous, C.T., Petre, E.N., Gonen, M., et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol 22:6 (2011), 755\u2013761.",
                        "@reference-instance-id": "OB2BibRecID-948433298-859f54958d08a8ae38de4dad2497a1b5-33",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib33",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79957572421",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "755",
                                    "@last": "761"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Sofocleous",
                                        "ce:indexed-name": "Sofocleous C.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Petre",
                                        "ce:indexed-name": "Petre E.N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Gonen",
                                        "ce:indexed-name": "Gonen M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Vasc Interv Radiol"
                        },
                        "ce:source-text": "Sofocleous CT, Petre EN, Gonen M, et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol. 2011;22(6):755-761."
                    },
                    {
                        "ref-fulltext": "de Ba√®re, T., Aup√©rin, A., Deschamps, F., et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 26:5 (2015), 987\u2013991.",
                        "@reference-instance-id": "OB2BibRecID-948433298-dc6b06180762ad651be078d873cf1d6a-34",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib34",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84929076387",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "987",
                                    "@last": "991"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "de Ba√®re",
                                        "ce:indexed-name": "de Baere T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Aup√©rin",
                                        "ce:indexed-name": "Auperin A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Deschamps",
                                        "ce:indexed-name": "Deschamps F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "de Baere T, Auperin A, Deschamps F, et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26(5):987-991."
                    },
                    {
                        "ref-fulltext": "de Baere, T., Tselikas, L., Woodrum, D., et al. Evaluating cryoablation of metastatic lung tumors in patients\u2014safety and efficacy: the ECLIPSE trial\u2014interim analysis at 1 year. J Thorac Oncol 10:10 (2015), 1468\u20131474.",
                        "@reference-instance-id": "OB2BibRecID-948433298-64d2080d151b1f83f71a6835d1a2d350-35",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Evaluating cryoablation of metastatic lung tumors in patients\u2014safety and efficacy: the ECLIPSE trial\u2014interim analysis at 1 year"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib35",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84942516354",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1468",
                                    "@last": "1474"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "de Baere",
                                        "ce:indexed-name": "de Baere T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Tselikas",
                                        "ce:indexed-name": "Tselikas L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Woodrum",
                                        "ce:indexed-name": "Woodrum D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "de Baere T, Tselikas L, Woodrum D, et al. Evaluating cryoablation of metastatic lung tumors in patients-safety and efficacy: the ECLIPSE trial-interim analysis at 1 year. J Thorac Oncol. 2015;10(10):1468-1474."
                    },
                    {
                        "ref-fulltext": "Gillams, A., Khan, Z., Osborn, P., et al. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. Cardiovasc Intervent Radiol 36:3 (2012), 724\u2013730.",
                        "@reference-instance-id": "OB2BibRecID-948433298-4e01e46cc75242a91a0aea69e8afba94-36",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib36",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84877756467",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "724",
                                    "@last": "730"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gillams",
                                        "ce:indexed-name": "Gillams A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Khan",
                                        "ce:indexed-name": "Khan Z."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Osborn",
                                        "ce:indexed-name": "Osborn P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cardiovasc Intervent Radiol"
                        },
                        "ce:source-text": "Gillams A, Khan Z, Osborn P, et al. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases. Cardiovasc Intervent Radiol. 2012;36(3):724-730."
                    },
                    {
                        "ref-fulltext": "Kurilova, I., Gonzalez-Aguirre, A., Beets-Tan, R.G., et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol 41:10 (2018), 1530\u20131544.",
                        "@reference-instance-id": "OB2BibRecID-948433298-5c1a9543cf3c810e08cbbdac7ceb94b6-37",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Microwave ablation in the management of colorectal cancer pulmonary metastases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib37",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85047662160",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "41",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1530",
                                    "@last": "1544"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Kurilova",
                                        "ce:indexed-name": "Kurilova I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gonzalez-Aguirre",
                                        "ce:indexed-name": "Gonzalez-Aguirre A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Beets-Tan",
                                        "ce:indexed-name": "Beets-Tan R.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cardiovasc Intervent Radiol"
                        },
                        "ce:source-text": "Kurilova I, Gonzalez-Aguirre A, Beets-Tan RG, et al. Microwave ablation in the management of colorectal cancer pulmonary metastases. Cardiovasc Intervent Radiol. 2018;41(10):1530-1544."
                    },
                    {
                        "ref-fulltext": "Kobiela, J., Spychalski, P., Marvaso, G., et al. Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: systematic review. Crit Rev Oncol Hematol 129 (2018), 91\u2013101.",
                        "@reference-instance-id": "OB2BibRecID-948433298-ea237b29293ac6b26e33d9904b4880ce-38",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: systematic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib38",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85049625349",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "129"},
                                "pagerange": {
                                    "@first": "91",
                                    "@last": "101"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Kobiela",
                                        "ce:indexed-name": "Kobiela J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Spychalski",
                                        "ce:indexed-name": "Spychalski P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Marvaso",
                                        "ce:indexed-name": "Marvaso G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Crit Rev Oncol Hematol"
                        },
                        "ce:source-text": "Kobiela J, Spychalski P, Marvaso G, et al. Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: systematic review. Crit Rev Oncol Hematol. 2018;129:91-101."
                    },
                    {
                        "ref-fulltext": "Tree, A.C., Khoo, V.S., Eeles, R.A., et al. Stereotactic body radiotherapy for oligometastases. Lancet Oncol 14:1 (2013), e28\u2013e37.",
                        "@reference-instance-id": "OB2BibRecID-948433298-662098db9f0d1ccec2e9069702c1fc24-39",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Stereotactic body radiotherapy for oligometastases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib39",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84871828017",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "e28",
                                    "@last": "e37"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Tree",
                                        "ce:indexed-name": "Tree A.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Khoo",
                                        "ce:indexed-name": "Khoo V.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Eeles",
                                        "ce:indexed-name": "Eeles R.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Tree AC, Khoo VS, Eeles RA, et al. Stereotactic body radiotherapy for oligometastases. Lancet Oncol. 2013;14(1):e28-e37."
                    },
                    {
                        "ref-fulltext": "Bokemeyer, C., K√∂hne, C.H., Ciardiello, F., et al. FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer. Eur J Cancer 51:10 (2015), 1243\u20131252.",
                        "@reference-instance-id": "OB2BibRecID-948433298-26d0cb85d52917015c04166fcf9e05dd-40",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib40",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84930047088",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "51",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1243",
                                    "@last": "1252"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Bokemeyer",
                                        "ce:indexed-name": "Bokemeyer C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "K√∂hne",
                                        "ce:indexed-name": "Kohne C.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Ciardiello",
                                        "ce:indexed-name": "Ciardiello F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Bokemeyer C, Kohne CH, Ciardiello F, et al. FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer. Eur J Cancer. 2015;51(10):1243-1252."
                    },
                    {
                        "ref-fulltext": "Douillard, J.Y., Oliner, K.S., Siena, S., et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med 369:11 (2013), 1023\u20131034.",
                        "@reference-instance-id": "OB2BibRecID-948433298-f317081f3ede48a4f6152e81f93f89ac-41",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib41",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84883680951",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "369",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1023",
                                    "@last": "1034"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Douillard",
                                        "ce:indexed-name": "Douillard J.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Oliner",
                                        "ce:indexed-name": "Oliner K.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Siena",
                                        "ce:indexed-name": "Siena S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Douillard JY, Oliner KS, Siena S, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369(11):1023-1034."
                    },
                    {
                        "ref-fulltext": "Douillard, J.Y., Siena, S., Cassidy, J., et al. Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer. Ann Oncol 25:7 (2014), 1346\u20131355.",
                        "@reference-instance-id": "OB2BibRecID-948433298-1f50d63ee714239c2446d01a6547404c-42",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib42",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84903694472",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "1346",
                                    "@last": "1355"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Douillard",
                                        "ce:indexed-name": "Douillard J.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Siena",
                                        "ce:indexed-name": "Siena S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cassidy",
                                        "ce:indexed-name": "Cassidy J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Douillard JY, Siena S, Cassidy J, et al. Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer. Ann Oncol. 2014;25(7):1346-1355."
                    },
                    {
                        "ref-fulltext": "Van Cutsem, E., Lenz, H.-J., K√∂hne, C.-H., et al. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. J Clin Oncol 33:7 (2015), 692\u2013700.",
                        "@reference-instance-id": "OB2BibRecID-948433298-9c5737bdca187c2eda2c2d2b5a558fdc-43",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib43",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84925324704",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "692",
                                    "@last": "700"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.-J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lenz",
                                        "ce:indexed-name": "Lenz H.-J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.-H.",
                                        "@_fa": "true",
                                        "ce:surname": "K√∂hne",
                                        "ce:indexed-name": "Kohne C.-H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Van Cutsem E, Lenz H-J, Kohne C-H, et al. Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer. J Clin Oncol. 2015;33(7):692-700."
                    },
                    {
                        "ref-fulltext": "Cunningham, D., Lang, I., Marcuello, E., et al. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. Lancet Oncol 14:11 (2013), 1077\u20131085.",
                        "@reference-instance-id": "OB2BibRecID-948433298-e6923882cad38bde634e067490df6d2f-44",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib44",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84884700039",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1077",
                                    "@last": "1085"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Cunningham",
                                        "ce:indexed-name": "Cunningham D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Lang",
                                        "ce:indexed-name": "Lang I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Marcuello",
                                        "ce:indexed-name": "Marcuello E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Cunningham D, Lang I, Marcuello E, et al. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. Lancet Oncol. 2013;14(11):1077-1085."
                    },
                    {
                        "ref-fulltext": "Hurwitz, H., Fehrenbacher, L., Novotny, W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:23 (2004), 2335\u20132342.",
                        "@reference-instance-id": "OB2BibRecID-948433298-83bd53ac5ce241da13d7c985cafb48ae-45",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib45",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "2542561964",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "350",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "2335",
                                    "@last": "2342"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Hurwitz",
                                        "ce:indexed-name": "Hurwitz H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Fehrenbacher",
                                        "ce:indexed-name": "Fehrenbacher L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Novotny",
                                        "ce:indexed-name": "Novotny W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335-2342."
                    },
                    {
                        "ref-fulltext": "Kabbinavar, F., Irl, C., Zurlo, A., et al. Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk. Oncology 75:3-4 (2008), 215\u2013223.",
                        "@reference-instance-id": "OB2BibRecID-948433298-590e11b1c7335a43bace14b502ac69f3-46",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib46",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "53549126631",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "75",
                                    "@issue": "3-4"
                                },
                                "pagerange": {
                                    "@first": "215",
                                    "@last": "223"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Kabbinavar",
                                        "ce:indexed-name": "Kabbinavar F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Irl",
                                        "ce:indexed-name": "Irl C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Zurlo",
                                        "ce:indexed-name": "Zurlo A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncology"
                        },
                        "ce:source-text": "Kabbinavar F, Irl C, Zurlo A, et al. Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk. Oncology. 2008;75(3-4):215-223."
                    },
                    {
                        "ref-fulltext": "Maughan, T.S., Adams, R.A., Smith, C.G., et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet 377:9783 (2011), 2103\u20132114.",
                        "@reference-instance-id": "OB2BibRecID-948433298-f887d2dd31b81fd3f0643eb488be5bbc-47",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib47",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79959337678",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "377",
                                    "@issue": "9783"
                                },
                                "pagerange": {
                                    "@first": "2103",
                                    "@last": "2114"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Maughan",
                                        "ce:indexed-name": "Maughan T.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Adams",
                                        "ce:indexed-name": "Adams R.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Smith",
                                        "ce:indexed-name": "Smith C.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Maughan TS, Adams RA, Smith CG, et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet. 2011;377(9783):2103-2114."
                    },
                    {
                        "ref-fulltext": "Qin, S., Li, J., Wang, L., et al. Efficacy and tolerability of first-line cetuximab plus leucovorin, fluorouracil, and oxaliplatin (FOLFOX-4) versus FOLFOX-4 in patients with RAS wild-type metastatic colorectal cancer: the open-label, randomized, phase III TAILOR trial. J Clin Oncol 36:30 (2018), 3031\u20133039.",
                        "@reference-instance-id": "OB2BibRecID-948433298-34f4436f44c582bd2fb58c803d4091b4-48",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Efficacy and tolerability of first-line cetuximab plus leucovorin, fluorouracil, and oxaliplatin (FOLFOX-4) versus FOLFOX-4 in patients with RAS wild-type metastatic colorectal cancer: the open-label, randomized, phase III TAILOR trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib48",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055085921",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "30"
                                },
                                "pagerange": {
                                    "@first": "3031",
                                    "@last": "3039"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qin",
                                        "ce:indexed-name": "Qin S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Qin S, Li J, Wang L, et al. Efficacy and tolerability of first-line cetuximab plus leucovorin, fluorouracil, and oxaliplatin (FOLFOX-4) versus FOLFOX-4 in patients with RAS wild-type metastatic colorectal cancer: the open-label, randomized, phase III TAILOR trial. J Clin Oncol. 2018;36(30):3031-3039."
                    },
                    {
                        "ref-fulltext": "Saltz, L.B., Clarke, S., Diaz-Rubio, E., et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26:12 (2008), 2013\u20132019.",
                        "@reference-instance-id": "OB2BibRecID-948433298-e2ad08db601e7779cece92dea73f3d22-49",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib49",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "42949149159",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "2013",
                                    "@last": "2019"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Saltz",
                                        "ce:indexed-name": "Saltz L.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Clarke",
                                        "ce:indexed-name": "Clarke S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Diaz-Rubio",
                                        "ce:indexed-name": "Diaz-Rubio E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Saltz LB, Clarke S, Diaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26(12):2013-2019."
                    },
                    {
                        "ref-fulltext": "Van Cutsem, E., K√∂hne, C.-H., Hitre, E., et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 360:14 (2009), 1408\u20131417.",
                        "@reference-instance-id": "OB2BibRecID-948433298-e889aef819fa6f01cd6cf91d347f8a19-50",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib50",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "63849088630",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "360",
                                    "@issue": "14"
                                },
                                "pagerange": {
                                    "@first": "1408",
                                    "@last": "1417"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.-H.",
                                        "@_fa": "true",
                                        "ce:surname": "K√∂hne",
                                        "ce:indexed-name": "Kohne C.-H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hitre",
                                        "ce:indexed-name": "Hitre E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Van Cutsem E, Kohne C-H, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360(14):1408-1417."
                    },
                    {
                        "ref-fulltext": "Rivera, F., Karthaus, M., Hecht, J.R., et al. Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma. Int J Colorectal Dis 32:8 (2017), 1179\u20131190.",
                        "@reference-instance-id": "OB2BibRecID-948433298-8ce348bffadb8d8e74b33cfef5613286-51",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib51",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85018471922",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1179",
                                    "@last": "1190"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Rivera",
                                        "ce:indexed-name": "Rivera F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Karthaus",
                                        "ce:indexed-name": "Karthaus M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Hecht",
                                        "ce:indexed-name": "Hecht J.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Colorectal Dis"
                        },
                        "ce:source-text": "Rivera F, Karthaus M, Hecht JR, et al. Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma. Int J Colorectal Dis. 2017;32(8):1179-1190."
                    },
                    {
                        "ref-fulltext": "Venook, A.P., Niedzwiecki, D., Innocenti, F., et al. Impact of primary (1¬∞) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): analysis of CALGB/SWOG 80405 (Alliance). J Clin Oncol, 34(suppl 15), 2016, 3504.",
                        "@reference-instance-id": "OB2BibRecID-948433298-ac335b26d8a399f19700174ef69bcbc1-52",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Impact of primary (1¬∞) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): analysis of CALGB/SWOG 80405 (Alliance)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib52",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84983782183",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {"@first": "3504"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Venook",
                                        "ce:indexed-name": "Venook A.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Niedzwiecki",
                                        "ce:indexed-name": "Niedzwiecki D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Innocenti",
                                        "ce:indexed-name": "Innocenti F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Venook AP, Niedzwiecki D, Innocenti F, et al. Impact of primary (1¬∞) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): analysis of CALGB/SWOG 80405 (Alliance). J Clin Oncol. 2016;34(suppl 15):3504"
                    },
                    {
                        "ref-fulltext": "Guren, T.K., Thomsen, M., Kure, E.H., et al. Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study. Br J Cancer 116:10 (2017), 1271\u20131278.",
                        "@reference-instance-id": "OB2BibRecID-948433298-4068805fa502ec35e9c5c85125667980-53",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib53",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85017417934",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "116",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1271",
                                    "@last": "1278"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Guren",
                                        "ce:indexed-name": "Guren T.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Thomsen",
                                        "ce:indexed-name": "Thomsen M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Kure",
                                        "ce:indexed-name": "Kure E.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Cancer"
                        },
                        "ce:source-text": "Guren TK, Thomsen M, Kure EH, et al. Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study. Br J Cancer. 2017;116(10):1271-1278."
                    },
                    {
                        "ref-fulltext": "Cremolini, C., Loupakis, F., Antoniotti, C., et al. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol 16:13 (2015), 1306\u20131315.",
                        "@reference-instance-id": "OB2BibRecID-948433298-7220fec4bab3347d02397a223d69a395-54",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib54",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84953856186",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "1306",
                                    "@last": "1315"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Cremolini",
                                        "ce:indexed-name": "Cremolini C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Loupakis",
                                        "ce:indexed-name": "Loupakis F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Antoniotti",
                                        "ce:indexed-name": "Antoniotti C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Cremolini C, Loupakis F, Antoniotti C, et al. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol. 2015;16(13):1306-1315."
                    },
                    {
                        "ref-fulltext": "Hegewisch-Becker, S., Graeven, U., Lerchenm√ºller, C.A., et al. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol 16:13 (2015), 1355\u20131369.",
                        "@reference-instance-id": "OB2BibRecID-948433298-3df7ec1a6142e89df965c5a50363c18b-55",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib55",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84954026956",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "1355",
                                    "@last": "1369"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hegewisch-Becker",
                                        "ce:indexed-name": "Hegewisch-Becker S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U.",
                                        "@_fa": "true",
                                        "ce:surname": "Graeven",
                                        "ce:indexed-name": "Graeven U."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Lerchenm√ºller",
                                        "ce:indexed-name": "Lerchenmuller C.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Hegewisch-Becker S, Graeven U, Lerchenmuller CA, et al. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2015;16(13):1355-1369."
                    },
                    {
                        "ref-fulltext": "Modest, D.P., Karthaus, M., Fruehauf, S., et al. Panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer: the randomized PANAMA trial (AIO KRK 0212). J Clin Oncol 40:1 (2022), 72\u201382.",
                        "@reference-instance-id": "OB2BibRecID-948433298-76f3e50113e9166eba54d355f278b03e-56",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer: the randomized PANAMA trial (AIO KRK 0212)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib56",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85118844548",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "40",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "72",
                                    "@last": "82"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Modest",
                                        "ce:indexed-name": "Modest D.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Karthaus",
                                        "ce:indexed-name": "Karthaus M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Fruehauf",
                                        "ce:indexed-name": "Fruehauf S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Modest DP, Karthaus M, Fruehauf S, et al. Panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer: the randomized PANAMA trial (AIO KRK 0212). J Clin Oncol. 2022;40(1):72-82."
                    },
                    {
                        "ref-fulltext": "Sobrero, A.F., Maurel, J., Fehrenbacher, L., et al. EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer. J Clin Oncol 26:14 (2008), 2311\u20132319.",
                        "@reference-instance-id": "OB2BibRecID-948433298-477bb24c12b49fd977d86f1343435f60-57",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib57",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "44249111440",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "14"
                                },
                                "pagerange": {
                                    "@first": "2311",
                                    "@last": "2319"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Sobrero",
                                        "ce:indexed-name": "Sobrero A.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Maurel",
                                        "ce:indexed-name": "Maurel J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Fehrenbacher",
                                        "ce:indexed-name": "Fehrenbacher L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Sobrero AF, Maurel J, Fehrenbacher L, et al. EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(14):2311-2319."
                    },
                    {
                        "ref-fulltext": "Peeters, M., Price, T.J., Cervantes, A., et al. Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer. Ann Oncol 25:1 (2014), 107\u2013116.",
                        "@reference-instance-id": "OB2BibRecID-948433298-d909d6557d7e481ed647022c367cec3a-58",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib58",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84899940235",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "107",
                                    "@last": "116"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Peeters",
                                        "ce:indexed-name": "Peeters M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Price",
                                        "ce:indexed-name": "Price T.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cervantes",
                                        "ce:indexed-name": "Cervantes A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Peeters M, Price TJ, Cervantes A, et al. Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer. Ann Oncol. 2014;25(1):107-116."
                    },
                    {
                        "ref-fulltext": "Giantonio, B.J., Catalano, P.J., Meropol, N.J., et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:12 (2007), 1539\u20131544.",
                        "@reference-instance-id": "OB2BibRecID-948433298-e353d77f143bc518bead360c27cbe3df-59",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib59",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34248173883",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "25",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1539",
                                    "@last": "1544"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Giantonio",
                                        "ce:indexed-name": "Giantonio B.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Catalano",
                                        "ce:indexed-name": "Catalano P.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Meropol",
                                        "ce:indexed-name": "Meropol N.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Giantonio BJ, Catalano PJ, Meropol NJ, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007;25(12):1539-1544."
                    },
                    {
                        "ref-fulltext": "Bennouna, J., Sastre, J., Arnold, D., et al. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. Lancet Oncol 14:1 (2013), 29\u201337.",
                        "@reference-instance-id": "OB2BibRecID-948433298-15dfab419282cc2d129c1e7c1faeed19-60",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib60",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84871720057",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "29",
                                    "@last": "37"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bennouna",
                                        "ce:indexed-name": "Bennouna J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Sastre",
                                        "ce:indexed-name": "Sastre J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Arnold",
                                        "ce:indexed-name": "Arnold D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Bennouna J, Sastre J, Arnold D, et al. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. Lancet Oncol. 2013;14(1):29-37."
                    },
                    {
                        "ref-fulltext": "Tabernero, J., Yoshino, T., Cohn, A.L., et al. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Lancet Oncol 16:5 (2015), 499\u2013508.",
                        "@reference-instance-id": "OB2BibRecID-948433298-dc72ac7aefaf473f72f8b859ede42360-61",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib61",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84933673498",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "499",
                                    "@last": "508"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tabernero",
                                        "ce:indexed-name": "Tabernero J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Cohn",
                                        "ce:indexed-name": "Cohn A.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Tabernero J, Yoshino T, Cohn AL, et al. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Lancet Oncol. 2015;16(5):499-508."
                    },
                    {
                        "ref-fulltext": "Van Cutsem, E., Tabernero, J., Lakomy, R., et al. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol 30:28 (2012), 3499\u20133506.",
                        "@reference-instance-id": "OB2BibRecID-948433298-549974382e9f076aa5a505e825d677fd-62",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib62",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84867047384",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "28"
                                },
                                "pagerange": {
                                    "@first": "3499",
                                    "@last": "3506"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tabernero",
                                        "ce:indexed-name": "Tabernero J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Lakomy",
                                        "ce:indexed-name": "Lakomy R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Van Cutsem E, Tabernero J, Lakomy R, et al. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol. 2012;30(28):3499-3506."
                    },
                    {
                        "ref-fulltext": "Tabernero, J., Grothey, A., Van Cutsem, E., et al. Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: updated survival results and subgroup analyses from the BEACON study. J Clin Oncol 39:4 (2021), 273\u2013284.",
                        "@reference-instance-id": "OB2BibRecID-948433298-2ef3c2292268e6050d96b68ab2c4713c-63",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: updated survival results and subgroup analyses from the BEACON study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib63",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100546706",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "39",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "273",
                                    "@last": "284"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tabernero",
                                        "ce:indexed-name": "Tabernero J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Grothey",
                                        "ce:indexed-name": "Grothey A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Tabernero J, Grothey A, Van Cutsem E, et al. Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E-mutant metastatic colorectal cancer: updated survival results and subgroup analyses from the BEACON study. J Clin Oncol. 2021;39(4):273-284."
                    },
                    {
                        "ref-fulltext": "Morse, M.A., Overman, M.J., Hartman, L., et al. Safety of nivolumab plus low-dose ipilimumab in previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. Oncologist 24:11 (2019), 1453\u20131461.",
                        "@reference-instance-id": "OB2BibRecID-948433298-ab8d070442a5d17ed82bc42e04b1322d-64",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Safety of nivolumab plus low-dose ipilimumab in previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib64",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066872267",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1453",
                                    "@last": "1461"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Morse",
                                        "ce:indexed-name": "Morse M.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Overman",
                                        "ce:indexed-name": "Overman M.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Hartman",
                                        "ce:indexed-name": "Hartman L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Morse MA, Overman MJ, Hartman L, et al. Safety of nivolumab plus low-dose ipilimumab in previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. Oncologist. 2019;24(11):1453-1461."
                    },
                    {
                        "ref-fulltext": "Overman, M.J., Lonardi, S., Wong, K.Y.M., et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol 36:8 (2018), 773\u2013779.",
                        "@reference-instance-id": "OB2BibRecID-948433298-eed3b29e3558ef91b4d1b8120b65caee-65",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib65",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85043396361",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "773",
                                    "@last": "779"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Overman",
                                        "ce:indexed-name": "Overman M.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lonardi",
                                        "ce:indexed-name": "Lonardi S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.Y.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Wong",
                                        "ce:indexed-name": "Wong K.Y.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018;36(8):773-779."
                    },
                    {
                        "ref-fulltext": "Overman, M.J., McDermott, R., Leach, J.L., et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol 18:9 (2017), 1182\u20131191.",
                        "@reference-instance-id": "OB2BibRecID-948433298-e8cc4c1f070c3288394b88d7d10915ae-66",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib66",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85025439295",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1182",
                                    "@last": "1191"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Overman",
                                        "ce:indexed-name": "Overman M.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "McDermott",
                                        "ce:indexed-name": "McDermott R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Leach",
                                        "ce:indexed-name": "Leach J.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Overman MJ, McDermott R, Leach JL, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182-1191."
                    },
                    {
                        "ref-fulltext": "Le, D.T., Kim, T.W., Van Cutsem, E., et al. Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164. J Clin Oncol 38:1 (2020), 11\u201319.",
                        "@reference-instance-id": "OB2BibRecID-948433298-5eea834f25edc618d2cf9522ff37649e-67",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib67",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076773847",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "11",
                                    "@last": "19"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Le",
                                        "ce:indexed-name": "Le D.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Le DT, Kim TW, Van Cutsem E, et al. Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164. J Clin Oncol. 2020;38(1):11-19."
                    },
                    {
                        "ref-fulltext": "Grothey, A., Cutsem, E.V., Sobrero, A., et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381:9863 (2013), 303\u2013312.",
                        "@reference-instance-id": "OB2BibRecID-948433298-43875cfe72dc91c155a560d99d4483f5-68",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib68",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84872921660",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "381",
                                    "@issue": "9863"
                                },
                                "pagerange": {
                                    "@first": "303",
                                    "@last": "312"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Grothey",
                                        "ce:indexed-name": "Grothey A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Cutsem",
                                        "ce:indexed-name": "Cutsem E.V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Sobrero",
                                        "ce:indexed-name": "Sobrero A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Grothey A, Cutsem EV, Sobrero A, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013;381(9863):303-312."
                    },
                    {
                        "ref-fulltext": "Li, J., Qin, S., Xu, R., et al. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 16:6 (2015), 619\u2013629.",
                        "@reference-instance-id": "OB2BibRecID-948433298-1887331a42a6653275f5daec7b7a9437-69",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib69",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84930276518",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "619",
                                    "@last": "629"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qin",
                                        "ce:indexed-name": "Qin S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Li J, Qin S, Xu R, et al. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2015;16(6):619-629."
                    },
                    {
                        "ref-fulltext": "Mayer, R.J., Van Cutsem, E., Falcone, A., et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med 372:20 (2015), 1909\u20131919.",
                        "@reference-instance-id": "OB2BibRecID-948433298-b053d4f2b6c13d60b053467a34ff2bb3-70",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Randomized trial of TAS-102 for refractory metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib70",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84929310633",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "372",
                                    "@issue": "20"
                                },
                                "pagerange": {
                                    "@first": "1909",
                                    "@last": "1919"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Mayer",
                                        "ce:indexed-name": "Mayer R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Falcone",
                                        "ce:indexed-name": "Falcone A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Mayer RJ, Van Cutsem E, Falcone A, et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med. 2015;372(20):1909-1919."
                    },
                    {
                        "ref-fulltext": "Tabernero, J., Prager, G.W., Fakih, M., et al. Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: the phase 3 randomized SUNLIGHT study. J Clin Oncol, 41, 2023, 4.",
                        "@reference-instance-id": "OB2BibRecID-948433298-69fcc5e3bcbf5f162d91b36d902ee912-71",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: the phase 3 randomized SUNLIGHT study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib71",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85150014594",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {"@first": "4"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tabernero",
                                        "ce:indexed-name": "Tabernero J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Prager",
                                        "ce:indexed-name": "Prager G.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Fakih",
                                        "ce:indexed-name": "Fakih M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Tabernero J, Prager GW, Fakih M, et al. Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: the phase 3 randomized SUNLIGHT study. J Clin Oncol. 2023;41:4."
                    },
                    {
                        "ref-fulltext": "Yoshino, T., Mizunuma, N., Yamazaki, K., et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol 13:10 (2012), 993\u20131001.",
                        "@reference-instance-id": "OB2BibRecID-948433298-2e89056b461bcde239f7f8d8c3684be4-72",
                        "@id": "72",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib72",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84866925889",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "993",
                                    "@last": "1001"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Mizunuma",
                                        "ce:indexed-name": "Mizunuma N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamazaki",
                                        "ce:indexed-name": "Yamazaki K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Yoshino T, Mizunuma N, Yamazaki K, et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol. 2012;13(10):993-1001."
                    },
                    {
                        "ref-fulltext": "Cunningham, D., Humblet, Y., Siena, S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:4 (2004), 337\u2013345.",
                        "@reference-instance-id": "OB2BibRecID-948433298-72efb4dcbc6f21d6788637ba04a4fe86-73",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib73",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "3242720345",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "351",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "337",
                                    "@last": "345"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Cunningham",
                                        "ce:indexed-name": "Cunningham D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Humblet",
                                        "ce:indexed-name": "Humblet Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Siena",
                                        "ce:indexed-name": "Siena S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351(4):337-345."
                    },
                    {
                        "ref-fulltext": "Hecht JR, Patnaik A., Berlin, J., et al. Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer. Cancer 110:5 (2007), 980\u2013988.",
                        "@reference-instance-id": "OB2BibRecID-948433298-f4158a70c188cb2864ca70a4ec2b262d-74",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib74",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34548147248",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "110",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "980",
                                    "@last": "988"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "ce:given-name": "Patnaik A.",
                                        "@seq": "1",
                                        "ce:initials": "P.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hecht JR",
                                        "ce:indexed-name": "Hecht JR P.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Berlin",
                                        "ce:indexed-name": "Berlin J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        },
                        "ce:source-text": "Hecht JR, Patnaik A, Berlin J, et al. Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer. Cancer. 2007;110(5):980-988."
                    },
                    {
                        "ref-fulltext": "Price, T.J., Peeters, M., Kim, T.W., et al. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study. Lancet Oncol 15:6 (2014), 569\u2013579.",
                        "@reference-instance-id": "OB2BibRecID-948433298-44eeec45c9afef99c4e03f18a844e293-75",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib75",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84899981129",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "569",
                                    "@last": "579"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Price",
                                        "ce:indexed-name": "Price T.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Peeters",
                                        "ce:indexed-name": "Peeters M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Price TJ, Peeters M, Kim TW, et al. Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study. Lancet Oncol. 2014;15(6):569-579."
                    },
                    {
                        "ref-fulltext": "Cremolini, C., Rossini, D., Dell'Aquila, E., et al. Rechallenge for patients with RAS and BRAF wild-type metastatic colorectal cancer with acquired resistance to first-line cetuximab and irinotecan: a phase 2 single-arm clinical trial. JAMA Oncol 5:3 (2019), 343\u2013350.",
                        "@reference-instance-id": "OB2BibRecID-948433298-7d55af35d813c6bcc2ca39baf0a38ed5-76",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Rechallenge for patients with RAS and BRAF wild-type metastatic colorectal cancer with acquired resistance to first-line cetuximab and irinotecan: a phase 2 single-arm clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib76",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057127256",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "343",
                                    "@last": "350"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Cremolini",
                                        "ce:indexed-name": "Cremolini C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Rossini",
                                        "ce:indexed-name": "Rossini D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Dell'Aquila",
                                        "ce:indexed-name": "Dell'Aquila E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Oncol"
                        },
                        "ce:source-text": "Cremolini C, Rossini D, Dell'Aquila E, et al. Rechallenge for patients with RAS and BRAF wild-type metastatic colorectal cancer with acquired resistance to first-line cetuximab and irinotecan: a phase 2 single-arm clinical trial. JAMA Oncol. 2019;5(3):343-350."
                    },
                    {
                        "ref-fulltext": "Martinelli, E., Martini, G., Famiglietti, V., et al. Cetuximab rechallenge plus avelumab in pretreated patients with RAS wild-type metastatic colorectal cancer: the phase 2 single-arm clinical CAVE trial. JAMA Oncol 7:10 (2021), 1529\u20131535.",
                        "@reference-instance-id": "OB2BibRecID-948433298-7f415693d9554e984dad69a1b96125c7-77",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Cetuximab rechallenge plus avelumab in pretreated patients with RAS wild-type metastatic colorectal cancer: the phase 2 single-arm clinical CAVE trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib77",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85113152505",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1529",
                                    "@last": "1535"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Martinelli",
                                        "ce:indexed-name": "Martinelli E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Martini",
                                        "ce:indexed-name": "Martini G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Famiglietti",
                                        "ce:indexed-name": "Famiglietti V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Oncol"
                        },
                        "ce:source-text": "Martinelli E, Martini G, Famiglietti V, et al. Cetuximab rechallenge plus avelumab in pretreated patients with RAS wild-type metastatic colorectal cancer: the phase 2 single-arm clinical CAVE trial. JAMA Oncol. 2021;7(10):1529-1535."
                    },
                    {
                        "ref-fulltext": "Dasari, N.A., Lonardi, S., Garcia-Carbonero, R., et al. LBA25 - FRESCO-2: a global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer. Ann Oncol 33 (2022), S808\u2013S869.",
                        "@reference-instance-id": "OB2BibRecID-948433298-f0a862a981aab325dec59057b7019d48-78",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "LBA25 - FRESCO-2: a global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib78",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85163249723",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "S808",
                                    "@last": "S869"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Dasari",
                                        "ce:indexed-name": "Dasari N.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lonardi",
                                        "ce:indexed-name": "Lonardi S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Garcia-Carbonero",
                                        "ce:indexed-name": "Garcia-Carbonero R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Dasari NA, Lonardi S, Garcia-Carbonero R, et al. LBA25 - FRESCO-2: a global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer. Ann Oncol. 2022;33:S808-S869."
                    },
                    {
                        "ref-fulltext": "Li, J., Qin, S., Xu, R.H., et al. Effect of fruquintinib vs placebo on overall survival in patients with previously treated metastatic colorectal cancer: the FRESCO randomized clinical trial. JAMA 319:24 (2018), 2486\u20132496.",
                        "@reference-instance-id": "OB2BibRecID-948433298-18c82892f8b9b3d274ebd247b08312fc-79",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Effect of fruquintinib vs placebo on overall survival in patients with previously treated metastatic colorectal cancer: the FRESCO randomized clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib79",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85049396459",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "319",
                                    "@issue": "24"
                                },
                                "pagerange": {
                                    "@first": "2486",
                                    "@last": "2496"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qin",
                                        "ce:indexed-name": "Qin S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu R.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA"
                        },
                        "ce:source-text": "Li J, Qin S, Xu RH, et al. Effect of fruquintinib vs placebo on overall survival in patients with previously treated metastatic colorectal cancer: the FRESCO randomized clinical trial. JAMA. 2018;319(24):2486-2496."
                    },
                    {
                        "ref-fulltext": "Meric-Bernstam, F., Hurwitz, H., Raghav, K.P.S., et al. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncol 20:4 (2019), 518\u2013530.",
                        "@reference-instance-id": "OB2BibRecID-948433298-78df9d3fa78d474098ae537616347205-80",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib80",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85063595326",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "518",
                                    "@last": "530"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Meric-Bernstam",
                                        "ce:indexed-name": "Meric-Bernstam F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Hurwitz",
                                        "ce:indexed-name": "Hurwitz H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.P.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Raghav",
                                        "ce:indexed-name": "Raghav K.P.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Meric-Bernstam F, Hurwitz H, Raghav KPS, et al. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncol. 2019;20(4):518-530."
                    },
                    {
                        "ref-fulltext": "Nakamura, Y., Okamoto, W., Kato, T., et al. Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial. Nat Med 27:11 (2021), 1899\u20131903.",
                        "@reference-instance-id": "OB2BibRecID-948433298-4ed7879cd15210547bcd4c4c174f9aff-81",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib81",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85118835260",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1899",
                                    "@last": "1903"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Nakamura",
                                        "ce:indexed-name": "Nakamura Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Okamoto",
                                        "ce:indexed-name": "Okamoto W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kato",
                                        "ce:indexed-name": "Kato T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Nakamura Y, Okamoto W, Kato T, et al. Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial. Nat Med. 2021;27(11):1899-1903."
                    },
                    {
                        "ref-fulltext": "Yoshino, T., Kotaka, M., Shinozaki, K., et al. JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer. Cancer Chemother Pharmacol 84:6 (2019), 1269\u20131277.",
                        "@reference-instance-id": "OB2BibRecID-948433298-747a319c12560e315d3333cda65c66c3-82",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib82",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073999229",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "84",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1269",
                                    "@last": "1277"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kotaka",
                                        "ce:indexed-name": "Kotaka M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shinozaki",
                                        "ce:indexed-name": "Shinozaki K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Chemother Pharmacol"
                        },
                        "ce:source-text": "Yoshino T, Kotaka M, Shinozaki K, et al. JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer. Cancer Chemother Pharmacol. 2019;84(6):1269-1277."
                    },
                    {
                        "ref-fulltext": "Yoshino, T., Yamanaka, T., Oki, E., et al. Efficacy and long-term peripheral sensory neuropathy of 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy for colon cancer: the ACHIEVE phase 3 randomized clinical trial. JAMA Oncol 5:11 (2019), 1574\u20131581.",
                        "@reference-instance-id": "OB2BibRecID-948433298-fe6d0b13071164bb8a02efb918cc130d-83",
                        "@id": "83",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Efficacy and long-term peripheral sensory neuropathy of 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy for colon cancer: the ACHIEVE phase 3 randomized clinical trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib83",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85072259781",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1574",
                                    "@last": "1581"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamanaka",
                                        "ce:indexed-name": "Yamanaka T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Oki",
                                        "ce:indexed-name": "Oki E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Oncol"
                        },
                        "ce:source-text": "Yoshino T, Yamanaka T, Oki E, et al. Efficacy and long-term peripheral sensory neuropathy of 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy for colon cancer: the ACHIEVE phase 3 randomized clinical trial. JAMA Oncol. 2019;5(11):1574-1581."
                    },
                    {
                        "ref-fulltext": "Kanai, M., Kawaguchi, T., Kotaka, M., et al. Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population. Cancer Med 12:7 (2023), 7808\u20137814.",
                        "@reference-instance-id": "OB2BibRecID-948433298-e5d8798d33f05d5de90cf58691a5588c-84",
                        "@id": "84",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib84",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85144166206",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "12",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "7808",
                                    "@last": "7814"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kanai",
                                        "ce:indexed-name": "Kanai M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kawaguchi",
                                        "ce:indexed-name": "Kawaguchi T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kotaka",
                                        "ce:indexed-name": "Kotaka M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Med"
                        },
                        "ce:source-text": "Kanai M, Kawaguchi T, Kotaka M, et al. Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population. Cancer Med. 2022. doi: 10.1002/cam4.5541."
                    },
                    {
                        "ref-fulltext": "Yeh, K.-H., PhD Dissertation. 1998, Graduate Institute of Clinical Medicine PhD. National Taiwan College of Medicine, Taipei, Taiwan, 151\u2013161 Chapter 5.2.2.",
                        "@reference-instance-id": "OB2BibRecID-948433298-9624ea4e62a5bc39187c27f8fa54f9dc-85",
                        "@id": "85",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1998"},
                            "ref-title": {"ref-titletext": "PhD Dissertation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib85",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85167841725",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {
                                "@first": "151",
                                "@last": "161"
                            }},
                            "ref-text": "Graduate Institute of Clinical Medicine PhD. National Taiwan College of Medicine, Taipei, Taiwan Chapter 5.2.2",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "K.-H.",
                                "@_fa": "true",
                                "ce:surname": "Yeh",
                                "ce:indexed-name": "Yeh K.-H."
                            }]}
                        },
                        "ce:source-text": "Yeh K-H. PhD Dissertation. Graduate Institute of Clinical Medicine PhD. National Taiwan College of Medicine, Taipei, Taiwan; 1998:Chapter 5.2.2, 151-161."
                    },
                    {
                        "ref-fulltext": "Cho, H.J., Park, Y.S., Kang, W.K., et al. Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity. Ther Drug Monit 29:2 (2007), 190\u2013196.",
                        "@reference-instance-id": "OB2BibRecID-948433298-b0f13f9fb38390876ca4feabbf550855-86",
                        "@id": "86",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib86",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34248157706",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "190",
                                    "@last": "196"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cho",
                                        "ce:indexed-name": "Cho H.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park Y.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kang",
                                        "ce:indexed-name": "Kang W.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther Drug Monit"
                        },
                        "ce:source-text": "Cho HJ, Park YS, Kang WK, et al. Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity. Ther Drug Monit. 2007;29(2):190-196."
                    },
                    {
                        "ref-fulltext": "Akiyama, Y., Fujita, K., Nagashima, F., et al. Genetic testing for UGT1A1‚àó28 and ‚àó6 in Japanese patients who receive irinotecan chemotherapy. Ann Oncol 19:12 (2008), 2089\u20132090.",
                        "@reference-instance-id": "OB2BibRecID-948433298-c5771f3bd47eccc8f4b977f7f4179de1-87",
                        "@id": "87",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Genetic testing for UGT1A1‚àó28 and ‚àó6 in Japanese patients who receive irinotecan chemotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib87",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "56749180965",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "2089",
                                    "@last": "2090"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Akiyama",
                                        "ce:indexed-name": "Akiyama Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Fujita",
                                        "ce:indexed-name": "Fujita K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Nagashima",
                                        "ce:indexed-name": "Nagashima F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Akiyama Y, Fujita K, Nagashima F, et al. Genetic testing for UGT1A1‚àó28 and ‚àó6 in Japanese patients who receive irinotecan chemotherapy. Ann Oncol. 2008;19(12):2089-2090."
                    },
                    {
                        "ref-fulltext": "Ando, Y., Saka, H., Ando, M., et al. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60:24 (2000), 6921\u20136926.",
                        "@reference-instance-id": "OB2BibRecID-948433298-c9bc6b14c8059d03d3e7ac7673bf27c1-88",
                        "@id": "88",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib88",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0034671387",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "60",
                                    "@issue": "24"
                                },
                                "pagerange": {
                                    "@first": "6921",
                                    "@last": "6926"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ando",
                                        "ce:indexed-name": "Ando Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Saka",
                                        "ce:indexed-name": "Saka H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Ando",
                                        "ce:indexed-name": "Ando M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Ando Y, Saka H, Ando M, et al. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res. 2000;60(24):6921-6926."
                    },
                    {
                        "ref-fulltext": "Cheng, L., Li, M., Hu, J., et al. UGT1A1‚àó6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians. Cancer Chemother Pharmacol 73:3 (2014), 551\u2013560.",
                        "@reference-instance-id": "OB2BibRecID-948433298-5802fba5a425f44419a84d7e5eeaa8fa-89",
                        "@id": "89",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "UGT1A1‚àó6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib89",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84896051392",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "73",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "551",
                                    "@last": "560"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Cheng",
                                        "ce:indexed-name": "Cheng L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Hu",
                                        "ce:indexed-name": "Hu J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Chemother Pharmacol"
                        },
                        "ce:source-text": "Cheng L, Li M, Hu J, et al. UGT1A1‚àó6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians. Cancer Chemother Pharmacol. 2014;73(3):551-560."
                    },
                    {
                        "ref-fulltext": "Kim, K.P., Kim, H.S., Sym, S.J., et al. A UGT1A1‚àó28 and ‚àó6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer. Cancer Chemother Pharmacol 71:6 (2013), 1609\u20131617.",
                        "@reference-instance-id": "OB2BibRecID-948433298-6d209f5b68955bcdc41efc45b7f03c07-90",
                        "@id": "90",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "A UGT1A1‚àó28 and ‚àó6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib90",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84878623032",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1609",
                                    "@last": "1617"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim K.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim H.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Sym",
                                        "ce:indexed-name": "Sym S.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Chemother Pharmacol"
                        },
                        "ce:source-text": "Kim KP, Kim HS, Sym SJ, et al. A UGT1A1‚àó28 and ‚àó6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer. Cancer Chemother Pharmacol. 2013;71(6):1609-1617."
                    },
                    {
                        "ref-fulltext": "Okuyama, Y., Hazama, S., Nozawa, H., et al. Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms. Jpn J Clin Oncol 41:4 (2011), 477\u2013482.",
                        "@reference-instance-id": "OB2BibRecID-948433298-ff1a0e91d86213b99702307e12663739-91",
                        "@id": "91",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib91",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79953737378",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "41",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "477",
                                    "@last": "482"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Okuyama",
                                        "ce:indexed-name": "Okuyama Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hazama",
                                        "ce:indexed-name": "Hazama S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Nozawa",
                                        "ce:indexed-name": "Nozawa H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Jpn J Clin Oncol"
                        },
                        "ce:source-text": "Okuyama Y, Hazama S, Nozawa H, et al. Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms. Jpn J Clin Oncol. 2011;41(4):477-482."
                    },
                    {
                        "ref-fulltext": "Satoh, T., Ura, T., Yamada, Y., et al. Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1‚àó28 and/or UGT1A1‚àó6 polymorphisms. Cancer Sci 102:10 (2011), 1868\u20131873.",
                        "@reference-instance-id": "OB2BibRecID-948433298-763134e4a32d588dcb2d13b30a2fc23a-92",
                        "@id": "92",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1‚àó28 and/or UGT1A1‚àó6 polymorphisms"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib92",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80053421316",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "102",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1868",
                                    "@last": "1873"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Satoh",
                                        "ce:indexed-name": "Satoh T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ura",
                                        "ce:indexed-name": "Ura T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamada",
                                        "ce:indexed-name": "Yamada Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Sci"
                        },
                        "ce:source-text": "Satoh T, Ura T, Yamada Y, et al. Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1‚àó28 and/or UGT1A1‚àó6 polymorphisms. Cancer Sci. 2011;102(10):1868-1873."
                    },
                    {
                        "ref-fulltext": "Su, Y.Y., Chiang, N.J., Chang, J.S., et al. The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan. ESMO Open, 8(1), 2023, 100746.",
                        "@reference-instance-id": "OB2BibRecID-948433298-cc01c17a6bdb0db77334519c3e4c8164-93",
                        "@id": "93",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib93",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "100746",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85143990891",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "8",
                                "@issue": "1"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Su",
                                        "ce:indexed-name": "Su Y.Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Chiang",
                                        "ce:indexed-name": "Chiang N.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Chang",
                                        "ce:indexed-name": "Chang J.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "ESMO Open"
                        },
                        "ce:source-text": "Su YY, Chiang NJ, Chang JS, et al. The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan. ESMO Open. 2023;8(1):100746."
                    },
                    {
                        "ref-fulltext": "Zhang, X., Yin, J.F., Zhang, J., et al. UGT1A1‚àó6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis. Cancer Chemother Pharmacol 80:1 (2017), 135\u2013149.",
                        "@reference-instance-id": "OB2BibRecID-948433298-5663acd3f9f50704a8518cc19d1305b5-94",
                        "@id": "94",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "UGT1A1‚àó6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib94",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85020189008",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "80",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "135",
                                    "@last": "149"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Yin",
                                        "ce:indexed-name": "Yin J.F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Chemother Pharmacol"
                        },
                        "ce:source-text": "Zhang X, Yin JF, Zhang J, et al. UGT1A1‚àó6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis. Cancer Chemother Pharmacol. 2017;80(1):135-149."
                    },
                    {
                        "ref-fulltext": "Yoshino, T., Watanabe, J., Shitara, K., et al. Panitumumab (PAN) plus mFOLFOX6 versus bevacizumab (BEV) plus mFOLFOX6 as first-line treatment in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC): results from the phase 3 PARADIGM trial. J Clin Oncol, 40, 2022, LBA1.",
                        "@reference-instance-id": "OB2BibRecID-948433298-52e94251601651341c5f1f762bb0ef2a-95",
                        "@id": "95",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Panitumumab (PAN) plus mFOLFOX6 versus bevacizumab (BEV) plus mFOLFOX6 as first-line treatment in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC): results from the phase 3 PARADIGM trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib95",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85137230699",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {"@first": "LBA1"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Watanabe",
                                        "ce:indexed-name": "Watanabe J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shitara",
                                        "ce:indexed-name": "Shitara K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Yoshino T, Watanabe J, Shitara K, et al. Panitumumab (PAN) plus mFOLFOX6 versus bevacizumab (BEV) plus mFOLFOX6 as first-line treatment in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC): results from the phase 3 PARADIGM trial. J Clin Oncol. 2022;40:LBA1."
                    },
                    {
                        "ref-fulltext": "Muro, K., Watanabe, J., Shitara, K., et al. First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results. Ann Oncol, 33, 2022, s377.",
                        "@reference-instance-id": "OB2BibRecID-948433298-fe8eaf1a9052b099bd74397c1efe0d71-96",
                        "@id": "96",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib96",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85167842428",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {"@first": "s377"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Muro",
                                        "ce:indexed-name": "Muro K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Watanabe",
                                        "ce:indexed-name": "Watanabe J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shitara",
                                        "ce:indexed-name": "Shitara K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Muro K, Watanabe J, Shitara K, et al. First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results. Ann Oncol. 2022;33:s377."
                    },
                    {
                        "ref-fulltext": "Shitara, K., Muro, K., Watanabe, J., et al. Negative hyperselection of patients with RAS wild-type metastatic colorectal cancer for panitumumab: a biomarker study of the phase III PARADIGM trial. J Clin Oncol, 41, 2023, 11.",
                        "@reference-instance-id": "OB2BibRecID-948433298-4f5509f1e077a99a1a7d8d024f30957f-97",
                        "@id": "97",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Negative hyperselection of patients with RAS wild-type metastatic colorectal cancer for panitumumab: a biomarker study of the phase III PARADIGM trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib97",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85158829453",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {"@first": "11"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shitara",
                                        "ce:indexed-name": "Shitara K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Muro",
                                        "ce:indexed-name": "Muro K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Watanabe",
                                        "ce:indexed-name": "Watanabe J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Shitara K, Muro K, Watanabe J, et al. Negative hyperselection of patients with RAS wild-type metastatic colorectal cancer for panitumumab: a biomarker study of the phase III PARADIGM trial. J Clin Oncol. 2023;41:11."
                    },
                    {
                        "ref-fulltext": "Modest, D.P., Martens, U.M., Riera-Knorrenschild, J., et al. FOLFOXIRI plus panitumumab as first-line treatment of RAS wild-type metastatic colorectal cancer: the randomized, open-label, phase II VOLFI study (AIO KRK0109). J Clin Oncol 37:35 (2019), 3401\u20133411.",
                        "@reference-instance-id": "OB2BibRecID-948433298-e16d2b7ac06e873a145cc9b4f9bf9d61-98",
                        "@id": "98",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "FOLFOXIRI plus panitumumab as first-line treatment of RAS wild-type metastatic colorectal cancer: the randomized, open-label, phase II VOLFI study (AIO KRK0109)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib98",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85076196288",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "37",
                                    "@issue": "35"
                                },
                                "pagerange": {
                                    "@first": "3401",
                                    "@last": "3411"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Modest",
                                        "ce:indexed-name": "Modest D.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "U.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Martens",
                                        "ce:indexed-name": "Martens U.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Riera-Knorrenschild",
                                        "ce:indexed-name": "Riera-Knorrenschild J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Modest DP, Martens UM, Riera-Knorrenschild J, et al. FOLFOXIRI plus panitumumab as first-line treatment of RAS wild-type metastatic colorectal cancer: the randomized, open-label, phase II VOLFI study (AIO KRK0109). J Clin Oncol. 2019;37(35):3401-3411."
                    },
                    {
                        "ref-fulltext": "Sunakawa, Y., Shiozawa, M., Watanabe, T., et al. Modified (m)-FOLFOXIRI plus cetuximab versus m-FOLFOXIRI plus bevacizumab as initial treatment of patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer: survival analysis of the phase II randomized DEEPER trial by JACCRO. J Clin Oncol, 41, 2023, 120.",
                        "@reference-instance-id": "OB2BibRecID-948433298-15293c701173992e6d702714e28be9f4-99",
                        "@id": "99",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Modified (m)-FOLFOXIRI plus cetuximab versus m-FOLFOXIRI plus bevacizumab as initial treatment of patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer: survival analysis of the phase II randomized DEEPER trial by JACCRO"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib99",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85158827095",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {"@first": "120"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Sunakawa",
                                        "ce:indexed-name": "Sunakawa Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Shiozawa",
                                        "ce:indexed-name": "Shiozawa M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Watanabe",
                                        "ce:indexed-name": "Watanabe T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Sunakawa Y, Shiozawa M, Watanabe T, et al. Modified (m)-FOLFOXIRI plus cetuximab versus m-FOLFOXIRI plus bevacizumab as initial treatment of patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer: survival analysis of the phase II randomized DEEPER trial by JACCRO. J Clin Oncol. 2023;41:120."
                    },
                    {
                        "ref-fulltext": "Rossini, D., Antoniotti, C., Lonardi, S., et al. Upfront modified fluorouracil, leucovorin, oxaliplatin, and irinotecan plus panitumumab versus fluorouracil, leucovorin, and oxaliplatin plus panitumumab for patients with RAS/BRAF wild-type metastatic colorectal cancer: the phase III TRIPLETE study by GONO. J Clin Oncol 40 (2022), 2878\u20132888.",
                        "@reference-instance-id": "OB2BibRecID-948433298-5dc097283ad4ce8375fb8f77af843e04-100",
                        "@id": "100",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Upfront modified fluorouracil, leucovorin, oxaliplatin, and irinotecan plus panitumumab versus fluorouracil, leucovorin, and oxaliplatin plus panitumumab for patients with RAS/BRAF wild-type metastatic colorectal cancer: the phase III TRIPLETE study by GONO"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib100",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85137134818",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "2878",
                                    "@last": "2888"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Rossini",
                                        "ce:indexed-name": "Rossini D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Antoniotti",
                                        "ce:indexed-name": "Antoniotti C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lonardi",
                                        "ce:indexed-name": "Lonardi S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Rossini D, Antoniotti C, Lonardi S, et al. Upfront modified fluorouracil, leucovorin, oxaliplatin, and irinotecan plus panitumumab versus fluorouracil, leucovorin, and oxaliplatin plus panitumumab for patients with RAS/BRAF wild-type metastatic colorectal cancer: the phase III TRIPLETE study by GONO. J Clin Oncol. 2022;40:2878-2888."
                    },
                    {
                        "ref-fulltext": "Terazawa, T., Kato, T., Goto, M., et al. Phase II study of panitumumab monotherapy in chemotherapy-naive frail or elderly patients with unresectable RAS wild-type colorectal cancer: OGSG 1602. Oncologist 26:1 (2021), e17\u2013e47.",
                        "@reference-instance-id": "OB2BibRecID-948433298-cf95a844108522fbc2fc77e503299d4a-101",
                        "@id": "101",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Phase II study of panitumumab monotherapy in chemotherapy-naive frail or elderly patients with unresectable RAS wild-type colorectal cancer: OGSG 1602"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib101",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85085053918",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "26",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "e17",
                                    "@last": "e47"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Terazawa",
                                        "ce:indexed-name": "Terazawa T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kato",
                                        "ce:indexed-name": "Kato T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Goto",
                                        "ce:indexed-name": "Goto M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Terazawa T, Kato T, Goto M, et al. Phase II study of panitumumab monotherapy in chemotherapy-naive frail or elderly patients with unresectable RAS wild-type colorectal cancer: OGSG 1602. Oncologist. 2021;26(1):e17-e47."
                    },
                    {
                        "ref-fulltext": "Osterlund, P., Kinos, S., Pfeiffer, P., et al. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study. ESMO Open, 7(3), 2022, 100427.",
                        "@reference-instance-id": "OB2BibRecID-948433298-5a7a8fa9ef5ae823ddbe1b47a428c9f6-102",
                        "@id": "102",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib102",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "100427",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85127304914",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "7",
                                "@issue": "3"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Osterlund",
                                        "ce:indexed-name": "Osterlund P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kinos",
                                        "ce:indexed-name": "Kinos S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Pfeiffer",
                                        "ce:indexed-name": "Pfeiffer P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "ESMO Open"
                        },
                        "ce:source-text": "Osterlund P, Kinos S, Pfeiffer P, et al. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study. ESMO Open. 2022;7(3):100427."
                    },
                    {
                        "ref-fulltext": "Diaz, L.A. Jr., Shiu, K.K., Kim, T.W., et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol 23:5 (2022), 659\u2013670.",
                        "@reference-instance-id": "OB2BibRecID-948433298-d10428fe61cebe8b3e8e2652960f5e9f-103",
                        "@id": "103",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib103",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85129197816",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "659",
                                    "@last": "670"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Diaz",
                                        "ce:suffix": "Jr.",
                                        "ce:indexed-name": "Diaz L.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shiu",
                                        "ce:indexed-name": "Shiu K.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Diaz LA, Jr., Shiu KK, Kim TW, et al. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 2022;23(5):659-670."
                    },
                    {
                        "ref-fulltext": "Yoshino, T., Andre, T., Kim, T.W., et al. Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer. Cancer Sci 114 (2023), 1026\u20131036.",
                        "@reference-instance-id": "OB2BibRecID-948433298-7e7920c871c569675e99ef1113c222c6-104",
                        "@id": "104",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib104",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85144036651",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "114"},
                                "pagerange": {
                                    "@first": "1026",
                                    "@last": "1036"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Yoshino",
                                        "ce:indexed-name": "Yoshino T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Andre",
                                        "ce:indexed-name": "Andre T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Sci"
                        },
                        "ce:source-text": "Yoshino T, Andre T, Kim TW, et al. Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer. Cancer Sci. 2023;114:1026-1036."
                    },
                    {
                        "ref-fulltext": "Mateo, J., Chakravarty, D., Dienstmann, R., et al. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). Ann Oncol 29:9 (2018), 1895\u20131902.",
                        "@reference-instance-id": "OB2BibRecID-948433298-5ebcca7b77ac3f7aa02f4b4b38ed0ab5-105",
                        "@id": "105",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib106",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054325308",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1895",
                                    "@last": "1902"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Mateo",
                                        "ce:indexed-name": "Mateo J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Chakravarty",
                                        "ce:indexed-name": "Chakravarty D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Dienstmann",
                                        "ce:indexed-name": "Dienstmann R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Mateo J, Chakravarty D, Dienstmann R, et al. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). Ann Oncol. 2018;29(9):1895-1902."
                    },
                    {
                        "ref-fulltext": "Stickler JH, Cerek A, Siena S, et al. Primary analysis of MOUNTAINEER: a phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC. European Society of Medical Oncology World Congress on Gastrointestinal Cancer Jun 29-Jul 2, 2022 2022:LBA2.",
                        "@reference-instance-id": "OB2BibRecID-948433298-aab9e08e67527be7dd525e531ce39bc7-106",
                        "@id": "106",
                        "ref-info": {
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib105",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85167842234",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Primary analysis of MOUNTAINEER: a phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC. European Society of Medical Oncology World Congress on Gastrointestinal Cancer Jun 29-Jul 2, 2022 2022:LBA2.",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Stickler",
                                        "ce:indexed-name": "Stickler J.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cerek",
                                        "ce:indexed-name": "Cerek A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Siena",
                                        "ce:indexed-name": "Siena S."
                                    }
                                ],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Stickler JH, Cerek A, Siena S, et al. Primary analysis of MOUNTAINEER: a phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC. European Society of Medical Oncology World Congress on Gastrointestinal Cancer Jun 29-Jul 2, 2022 2022:LBA2."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Fukuoka",
            "@id": "60185923",
            "affilname": "Graduate School of Medical Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60185923",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Central Jakarta",
            "@id": "60069378",
            "affilname": "Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069378",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60276990",
            "affilname": "The Catholic University of Korea Seoul St. Mary's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60276990",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Madrid",
            "@id": "60271969",
            "affilname": "Centro de Investigaci√≥n Biom√©dica en Red de C√°ncer",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60271969",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Sendai",
            "@id": "60180317",
            "affilname": "Graduate School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60180317",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Hangzhou",
            "@id": "60118432",
            "affilname": "The Second Affiliated Hospital Zhejiang University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118432",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60082502",
            "affilname": "Sun Yat-Sen University Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kaohsiung",
            "@id": "60073387",
            "affilname": "Kaohsiung Medical University Chung-Ho Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073387",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Manila",
            "@id": "60071478",
            "affilname": "Philippine General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071478",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Manila",
            "@id": "60071449",
            "affilname": "University of the Philippines College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071449",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031809",
            "affilname": "National Cancer Centre, Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60030442",
            "affilname": "Istituto Europeo di Oncologia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030442",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60030318",
            "affilname": "Universit√† degli Studi di Milano",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Nagoya",
            "@id": "60028476",
            "affilname": "Aichi Cancer Center Hospital and Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028476",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Naples",
            "@id": "60026777",
            "affilname": "Universit√† degli Studi della Campania Luigi Vanvitelli",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026777",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60025370",
            "affilname": "National Taiwan University College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025370",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Lausanne",
            "@id": "60023561",
            "affilname": "Centre Hospitalier Universitaire Vaudois",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023561",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Kawasaki",
            "@id": "60012275",
            "affilname": "St. Marianna University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012275",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Sendai",
            "@id": "60011374",
            "affilname": "Tohoku University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011374",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Kashiwa",
            "@id": "60010925",
            "affilname": "National Cancer Center Hospital East",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Zhunan",
            "@id": "60010037",
            "affilname": "National Health Research Institutes Taiwan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010037",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bengaluru",
            "@id": "60005996",
            "affilname": "St. John's Medical College",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005996",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Valencia",
            "@id": "60002644",
            "affilname": "Universitat de Val√®ncia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002644",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Vellore",
            "@id": "60000653",
            "affilname": "Christian Medical College, Vellore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000653",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Nilai",
            "@id": "129768385",
            "affilname": "Aurelius Hospital Nilai",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/129768385",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Petaling Jaya",
            "@id": "121989463",
            "affilname": "Thomson Hospital Kota Damansara",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/121989463",
            "affiliation-country": "Malaysia"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85160253356",
        "dc:description": "The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer (mCRC), published in late 2022, were adapted in December 2022, according to previously established standard methodology, to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for the management of Asian patients with mCRC. The adapted guidelines presented in this manuscript represent the consensus opinions reached by a panel of Asian experts in the treatment of patients with mCRC representing the oncological societies of China (CSCO), Indonesia (ISHMO), India (ISMPO), Japan (JSMO), Korea (KSMO), Malaysia (MOS), the Philippines (PSMO), Singapore (SSO), Taiwan (TOS) and Thailand (TSCO), co-ordinated by ESMO and the Japanese Society of Medical Oncology (JSMO). The voting was based on scientific evidence and was independent of the current treatment practices, drug access restrictions and reimbursement decisions in the different Asian countries. The latter are discussed separately in the manuscript. The aim is to provide guidance for the optimisation and harmonisation of the management of patients with mCRC across the different countries of Asia, drawing on the evidence provided by both Western and Asian trials, whilst respecting the differences in screening practices, molecular profiling and age and stage at presentation, coupled with a disparity in the drug approvals and reimbursement strategies, between the different countries.",
        "pubmed-id": "37236086",
        "prism:coverDate": "2023-06-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85160253356",
        "dc:creator": {"author": [{
            "preferred-name": {
                "ce:given-name": "T.",
                "ce:initials": "T.",
                "ce:surname": "Yoshino",
                "ce:indexed-name": "Yoshino T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:surname": "Yoshino",
            "@auid": "57205400013",
            "author-url": "https://api.elsevier.com/content/author/author_id/57205400013",
            "ce:indexed-name": "Yoshino T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85160253356"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85160253356&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85160253356&origin=inward"
            }
        ],
        "source-id": "21100873339",
        "pii": "S2059702923007846",
        "citedby-count": "1",
        "prism:volume": "8",
        "subtype": "ar",
        "dc:title": "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer",
        "openaccess": "1",
        "prism:issn": "20597029",
        "publishercopyright": "¬© 2023 The Authors",
        "article-number": "101558",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "ESMO Open",
        "openaccessFlag": "true",
        "prism:doi": "10.1016/j.esmoop.2023.101558",
        "dc:identifier": "SCOPUS_ID:85160253356",
        "dc:publisher": "Elsevier B.V."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Asia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Colonic Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Follow-Up Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Medical Oncology",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Societies, Medical",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "ESMO"
        },
        {
            "@_fa": "true",
            "$": "guidelines"
        },
        {
            "@_fa": "true",
            "$": "metastatic colorectal cancer"
        },
        {
            "@_fa": "true",
            "$": "Pan-Asian"
        },
        {
            "@_fa": "true",
            "$": "treatment"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "preferred-name": {
                "ce:given-name": "T.",
                "ce:initials": "T.",
                "ce:surname": "Yoshino",
                "ce:indexed-name": "Yoshino T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:surname": "Yoshino",
            "@auid": "57205400013",
            "author-url": "https://api.elsevier.com/content/author/author_id/57205400013",
            "ce:indexed-name": "Yoshino T."
        },
        {
            "preferred-name": {
                "ce:given-name": "A.",
                "ce:initials": "A.",
                "ce:surname": "Cervantes",
                "ce:indexed-name": "Cervantes A."
            },
            "@seq": "2",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002644",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002644"
                },
                {
                    "@id": "60271969",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60271969"
                }
            ],
            "ce:surname": "Cervantes",
            "@auid": "7006000690",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006000690",
            "ce:indexed-name": "Cervantes A."
        },
        {
            "preferred-name": {
                "ce:given-name": "H.",
                "ce:initials": "H.",
                "ce:surname": "Bando",
                "ce:indexed-name": "Bando H."
            },
            "@seq": "3",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:surname": "Bando",
            "@auid": "28267511400",
            "author-url": "https://api.elsevier.com/content/author/author_id/28267511400",
            "ce:indexed-name": "Bando H."
        },
        {
            "preferred-name": {
                "ce:given-name": "E.",
                "ce:initials": "E.",
                "ce:surname": "Martinelli",
                "ce:indexed-name": "Martinelli E."
            },
            "@seq": "4",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026777",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026777"
            },
            "ce:surname": "Martinelli",
            "@auid": "7005920149",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005920149",
            "ce:indexed-name": "Martinelli E."
        },
        {
            "preferred-name": {
                "ce:given-name": "E.",
                "ce:initials": "E.",
                "ce:surname": "Oki",
                "ce:indexed-name": "Oki E."
            },
            "@seq": "5",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60185923",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60185923"
            },
            "ce:surname": "Oki",
            "@auid": "34572593400",
            "author-url": "https://api.elsevier.com/content/author/author_id/34572593400",
            "ce:indexed-name": "Oki E."
        },
        {
            "preferred-name": {
                "ce:given-name": "R. H.",
                "ce:initials": "R.H.",
                "ce:surname": "Xu",
                "ce:indexed-name": "Xu R.H."
            },
            "@seq": "6",
            "ce:initials": "R.-H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60082502",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502"
            },
            "ce:surname": "Xu",
            "@auid": "8662243500",
            "author-url": "https://api.elsevier.com/content/author/author_id/8662243500",
            "ce:indexed-name": "Xu R.-H."
        },
        {
            "preferred-name": {
                "ce:given-name": "N. A.",
                "ce:initials": "N.A.",
                "ce:surname": "Mulansari",
                "ce:indexed-name": "Mulansari N.A."
            },
            "@seq": "7",
            "ce:initials": "N.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60069378",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069378"
            },
            "ce:surname": "Mulansari",
            "@auid": "36519326000",
            "author-url": "https://api.elsevier.com/content/author/author_id/36519326000",
            "ce:indexed-name": "Mulansari N.A."
        },
        {
            "preferred-name": {
                "ce:given-name": "K.",
                "ce:initials": "K.",
                "ce:surname": "Govind Babu",
                "ce:indexed-name": "Govind Babu K."
            },
            "@seq": "8",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005996",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005996"
            },
            "ce:surname": "Govind Babu",
            "@auid": "6507009848",
            "author-url": "https://api.elsevier.com/content/author/author_id/6507009848",
            "ce:indexed-name": "Govind Babu K."
        },
        {
            "preferred-name": {
                "ce:given-name": "M. A.",
                "ce:initials": "M.A.",
                "ce:surname": "Lee",
                "ce:indexed-name": "Lee M.A."
            },
            "@seq": "9",
            "ce:initials": "M.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60276990",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60276990"
            },
            "ce:surname": "Lee",
            "@auid": "58003653900",
            "author-url": "https://api.elsevier.com/content/author/author_id/58003653900",
            "ce:indexed-name": "Lee M.A."
        },
        {
            "preferred-name": {
                "ce:given-name": "C. K.",
                "ce:initials": "C.K.",
                "ce:surname": "Tan",
                "ce:indexed-name": "Tan C.K."
            },
            "@seq": "10",
            "ce:initials": "C.K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "121989463",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/121989463"
            },
            "ce:surname": "Tan",
            "@auid": "58288943100",
            "author-url": "https://api.elsevier.com/content/author/author_id/58288943100",
            "ce:indexed-name": "Tan C.K."
        },
        {
            "preferred-name": {
                "ce:given-name": "G.",
                "ce:initials": "G.",
                "ce:surname": "Cornelio",
                "ce:indexed-name": "Cornelio G."
            },
            "@seq": "11",
            "ce:initials": "G.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60071478",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071478"
            },
            "ce:surname": "Cornelio",
            "@auid": "6603213207",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603213207",
            "ce:indexed-name": "Cornelio G."
        },
        {
            "preferred-name": {
                "ce:given-name": "D. Q.",
                "ce:initials": "D.Q.",
                "ce:surname": "Chong",
                "ce:indexed-name": "Chong D.Q."
            },
            "@seq": "12",
            "ce:initials": "D.Q.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031809",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809"
            },
            "ce:surname": "Chong",
            "@auid": "55533963500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55533963500",
            "ce:indexed-name": "Chong D.Q."
        },
        {
            "preferred-name": {
                "ce:given-name": "L. T.",
                "ce:initials": "L.T.",
                "ce:surname": "Chen",
                "ce:indexed-name": "Chen L.T."
            },
            "@seq": "13",
            "ce:initials": "L.-T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60073387",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073387"
                },
                {
                    "@id": "60010037",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010037"
                }
            ],
            "ce:surname": "Chen",
            "@auid": "7409440415",
            "author-url": "https://api.elsevier.com/content/author/author_id/7409440415",
            "ce:indexed-name": "Chen L.-T."
        },
        {
            "preferred-name": {
                "ce:given-name": "S.",
                "ce:initials": "S.",
                "ce:surname": "Tanasanvimon",
                "ce:indexed-name": "Tanasanvimon S."
            },
            "@seq": "14",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Tanasanvimon",
            "@auid": "23089332900",
            "author-url": "https://api.elsevier.com/content/author/author_id/23089332900",
            "ce:indexed-name": "Tanasanvimon S."
        },
        {
            "preferred-name": {
                "ce:given-name": "N.",
                "ce:initials": "N.",
                "ce:surname": "Prasongsook",
                "ce:indexed-name": "Prasongsook N."
            },
            "@seq": "15",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006964",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964"
            },
            "ce:surname": "Prasongsook",
            "@auid": "57191860850",
            "author-url": "https://api.elsevier.com/content/author/author_id/57191860850",
            "ce:indexed-name": "Prasongsook N."
        },
        {
            "preferred-name": {
                "ce:given-name": "K. H.",
                "ce:initials": "K.H.",
                "ce:surname": "Yeh",
                "ce:indexed-name": "Yeh K.H."
            },
            "@seq": "16",
            "ce:initials": "K.-H.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60073385",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"
                },
                {
                    "@id": "60025370",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025370"
                }
            ],
            "ce:surname": "Yeh",
            "@auid": "7201438906",
            "author-url": "https://api.elsevier.com/content/author/author_id/7201438906",
            "ce:indexed-name": "Yeh K.-H."
        },
        {
            "preferred-name": {
                "ce:given-name": "C.",
                "ce:initials": "C.",
                "ce:surname": "Chua",
                "ce:indexed-name": "Chua C."
            },
            "@seq": "17",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031809",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809"
            },
            "ce:surname": "Chua",
            "@auid": "55639224600",
            "author-url": "https://api.elsevier.com/content/author/author_id/55639224600",
            "ce:indexed-name": "Chua C."
        },
        {
            "preferred-name": {
                "ce:given-name": "M. D.",
                "ce:initials": "M.D.",
                "ce:surname": "Sacdalan",
                "ce:indexed-name": "Sacdalan M.D."
            },
            "@seq": "18",
            "ce:initials": "M.D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60071449",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071449"
            },
            "ce:surname": "Sacdalan",
            "@auid": "57201651001",
            "author-url": "https://api.elsevier.com/content/author/author_id/57201651001",
            "ce:indexed-name": "Sacdalan M.D."
        },
        {
            "preferred-name": {
                "ce:given-name": "W. J.",
                "ce:initials": "W.J.",
                "ce:surname": "Sow (Jenson)",
                "ce:indexed-name": "Sow (Jenson) W.J."
            },
            "@seq": "19",
            "ce:initials": "W.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "129768385",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/129768385"
            },
            "ce:surname": "Sow (Jenson)",
            "@auid": "58289728300",
            "author-url": "https://api.elsevier.com/content/author/author_id/58289728300",
            "ce:indexed-name": "Sow (Jenson) W.J."
        },
        {
            "preferred-name": {
                "ce:given-name": "S. T.",
                "ce:initials": "S.T.",
                "ce:surname": "Kim",
                "ce:indexed-name": "Kim S.T."
            },
            "@seq": "20",
            "ce:initials": "S.T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016329",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329"
            },
            "ce:surname": "Kim",
            "@auid": "56569111000",
            "author-url": "https://api.elsevier.com/content/author/author_id/56569111000",
            "ce:indexed-name": "Kim S.T."
        },
        {
            "preferred-name": {
                "ce:given-name": "R. T.",
                "ce:initials": "R.T.",
                "ce:surname": "Chacko",
                "ce:indexed-name": "Chacko R.T."
            },
            "@seq": "21",
            "ce:initials": "R.T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000653",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000653"
            },
            "ce:surname": "Chacko",
            "@auid": "26659876000",
            "author-url": "https://api.elsevier.com/content/author/author_id/26659876000",
            "ce:indexed-name": "Chacko R.T."
        },
        {
            "preferred-name": {
                "ce:given-name": "R. A.",
                "ce:initials": "R.A.",
                "ce:surname": "Syaiful",
                "ce:indexed-name": "Syaiful R.A."
            },
            "@seq": "22",
            "ce:initials": "R.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60069378",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069378"
            },
            "ce:surname": "Syaiful",
            "@auid": "57214818481",
            "author-url": "https://api.elsevier.com/content/author/author_id/57214818481",
            "ce:indexed-name": "Syaiful R.A."
        },
        {
            "preferred-name": {
                "ce:given-name": "S. Z.",
                "ce:initials": "S.Z.",
                "ce:surname": "Zhang",
                "ce:indexed-name": "Zhang S.Z."
            },
            "@seq": "23",
            "ce:initials": "S.Z.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60118432",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118432"
            },
            "ce:surname": "Zhang",
            "@auid": "23391621200",
            "author-url": "https://api.elsevier.com/content/author/author_id/23391621200",
            "ce:indexed-name": "Zhang S.Z."
        },
        {
            "preferred-name": {
                "ce:given-name": "G.",
                "ce:initials": "G.",
                "ce:surname": "Curigliano",
                "ce:indexed-name": "Curigliano G."
            },
            "@seq": "24",
            "ce:initials": "G.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60030442",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030442"
                },
                {
                    "@id": "60030318",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030318"
                }
            ],
            "ce:surname": "Curigliano",
            "@auid": "57221578995",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221578995",
            "ce:indexed-name": "Curigliano G."
        },
        {
            "preferred-name": {
                "ce:given-name": "S.",
                "ce:initials": "S.",
                "ce:surname": "Mishima",
                "ce:indexed-name": "Mishima S."
            },
            "@seq": "25",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:surname": "Mishima",
            "@auid": "57203743338",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203743338",
            "ce:indexed-name": "Mishima S."
        },
        {
            "preferred-name": {
                "ce:given-name": "Y.",
                "ce:initials": "Y.",
                "ce:surname": "Nakamura",
                "ce:indexed-name": "Nakamura Y."
            },
            "@seq": "26",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:surname": "Nakamura",
            "@auid": "55726843400",
            "author-url": "https://api.elsevier.com/content/author/author_id/55726843400",
            "ce:indexed-name": "Nakamura Y."
        },
        {
            "preferred-name": {
                "ce:given-name": "H.",
                "ce:initials": "H.",
                "ce:surname": "Ebi",
                "ce:indexed-name": "Ebi H."
            },
            "@seq": "27",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028476",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028476"
            },
            "ce:surname": "Ebi",
            "@auid": "6603124271",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603124271",
            "ce:indexed-name": "Ebi H."
        },
        {
            "preferred-name": {
                "ce:given-name": "Y.",
                "ce:initials": "Y.",
                "ce:surname": "Sunakawa",
                "ce:indexed-name": "Sunakawa Y."
            },
            "@seq": "28",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012275",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012275"
            },
            "ce:surname": "Sunakawa",
            "@auid": "23669095300",
            "author-url": "https://api.elsevier.com/content/author/author_id/23669095300",
            "ce:indexed-name": "Sunakawa Y."
        },
        {
            "preferred-name": {
                "ce:given-name": "M.",
                "ce:initials": "M.",
                "ce:surname": "Takahashi",
                "ce:indexed-name": "Takahashi M."
            },
            "@seq": "29",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60180317",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60180317"
            },
            "ce:surname": "Takahashi",
            "@auid": "55619302848",
            "author-url": "https://api.elsevier.com/content/author/author_id/55619302848",
            "ce:indexed-name": "Takahashi M."
        },
        {
            "preferred-name": {
                "ce:given-name": "E.",
                "ce:initials": "E.",
                "ce:surname": "Baba",
                "ce:indexed-name": "Baba E."
            },
            "@seq": "30",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60185923",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60185923"
            },
            "ce:surname": "Baba",
            "@auid": "7005105717",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005105717",
            "ce:indexed-name": "Baba E."
        },
        {
            "preferred-name": {
                "ce:given-name": "S.",
                "ce:initials": "S.",
                "ce:surname": "Peters",
                "ce:indexed-name": "Peters S."
            },
            "@seq": "31",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60023561",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023561"
            },
            "ce:surname": "Peters",
            "@auid": "57218315686",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218315686",
            "ce:indexed-name": "Peters S."
        },
        {
            "preferred-name": {
                "ce:given-name": "C.",
                "ce:initials": "C.",
                "ce:surname": "Ishioka",
                "ce:indexed-name": "Ishioka C."
            },
            "@seq": "32",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011374",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011374"
            },
            "ce:surname": "Ishioka",
            "@auid": "7005354286",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005354286",
            "ce:indexed-name": "Ishioka C."
        },
        {
            "preferred-name": {
                "ce:given-name": "G.",
                "ce:initials": "G.",
                "ce:surname": "Pentheroudakis",
                "ce:indexed-name": "Pentheroudakis G."
            },
            "@seq": "33",
            "ce:initials": "G.",
            "@_fa": "true",
            "ce:surname": "Pentheroudakis",
            "@auid": "56230606500",
            "author-url": "https://api.elsevier.com/content/author/author_id/56230606500",
            "ce:indexed-name": "Pentheroudakis G."
        }
    ]}
}}